pmid	doi	year	title	Hugo_Symbol
34060394	10.1080/01635581.2021.1931700	2022	Britannin a Sesquiterpene Lactone from <i>Inula aucheriana</i> Exerted an Anti-leukemic Effect in Acute Lymphoblastic Leukemia (ALL) Cells and Enhanced the Sensitivity of the Cells to Vincristine.	BCL2
34082607	10.1177/11206721211023309	2022	Follicular lymphoma of the ocular adnexa: Clinicopathological findings with flow cytometry analysis of eight cases.	BCL2
34180720	10.1177/10668969211027409	2022	Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.	BCL2
34184213	10.1007/s12011-021-02802-2	2022	Borax Pentahydrate and Disodium Pentaborate Decahydrate Are Candidates as Anti-leukemic Drug Components by Inducing Apoptosis and Changing Bax/Bcl-2 Ratio in HL-60 Cell Line.	BCL2
34236820	10.21470/1678-9741-2020-0549	2022	The Protective Effect of Kaempferol Against Ischemia/Reperfusion Injury Through Activating SIRT3 to Inhibit Oxidative Stress.	BCL2
34265801	10.1097/PAS.0000000000001780	2022	Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation.	BCL2
34289655	10.3324/haematol.2021.278638	2022	Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.	BCL2
34304248	10.1038/s41375-021-01347-6	2022	Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma.	BCL2
34314292	10.1080/15321819.2021.1954948	2022	Expression of Friend Leukemia Integration-1 (Fli-1) and the Apoptosis Regulator B Cell Lymphoma-2 (BCL-2) in Gastric Carcinoma; an Immunohistochemical Study.	BCL2
34332791	10.1016/j.pathol.2021.04.008	2022	Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.	BCL2
34353221	10.1080/15376516.2021.1965276	2022	Concerted hepatoprotective effect of bradykinin potentiating factor and low dose of γ- radiation on <i>Naja haje</i> envenomed rats <i>via</i> Bax/Bcl2 pathway.	BCL2
34392269	10.1097/PAS.0000000000001750	2022	Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity.	BCL2
34411492	10.1139/cjpp-2021-0007	2022	Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and <i>BAX</i> and <i>Bcl-2</i> gene expression.	BCL2
34417692	10.1007/s11356-021-15985-x	2022	Landfill soil leachates from Nigeria and India induced DNA damage and alterations in genes associated with apoptosis in Jurkat cell.	BCL2
34454850	10.1016/j.clml.2021.07.020	2022	Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.	BCL2
34456240	10.1097/PAI.0000000000000967	2022	Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting.	BCL2
34510996	10.1080/10428194.2021.1975189	2022	<i>BCL2</i> translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival.	BCL2
34515880	10.1007/s10238-021-00754-4	2022	Programmed cell death-ligand 1 (PD-L1)<sup>+</sup> tumour cells and low-reacting programmed cell death 1 (PD1)<sup>+</sup> tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus<sup>+</sup> diffuse large B-cell lymphoma.	BCL2
34519021	10.1111/bjh.17815	2022	Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.	BCL2
34528680	10.1093/ajcp/aqab128	2022	Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.	BCL2
34530171	10.1016/j.bone.2021.116182	2022	Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m<sup>6</sup>A modification.	BCL2
34532813	10.1007/s11010-021-04257-4	2022	Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis.	BCL2
34538551	10.1016/j.jfma.2021.08.015	2022	Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats.	BCL2
34601504	10.1038/s41379-021-00938-z	2022	Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation.	BCL2
34601571	10.1182/blood.2021013156	2022	Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.	BCL2
34605949	10.1007/s00277-021-04671-0	2022	Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma.	BCL2
34608246	10.1038/s41379-021-00909-4	2022	Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.	BCL2
34615723	10.1158/1078-0432.CCR-21-2183	2022	Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.	BCL2
34617271	10.1111/bjh.17874	2022	Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.	BCL2
34624089	10.1182/blood.2021012327	2022	Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas.	BCL2
34632572	10.1111/bjh.17858	2022	Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.	BCL2
34632715	10.1002/1878-0261.13115	2022	Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma.	BCL2
34637146	10.1111/his.14585	2022	EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study.	BCL2
34654055	10.1182/bloodadvances.2021006034	2022	Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.	BCL2
34673010	10.1016/j.cbi.2021.109703	2022	The effects of agomelatine on endoplasmic reticulum stress related to mitochondrial dysfunction in hippocampus of aging rat model.	BCL2
34710243	10.1002/ajh.26390	2022	Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.	BCL2
34713475	10.1002/hon.2943	2022	Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.	BCL2
34727403	10.1111/pin.13182	2022	AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.	BCL2
34727633	10.5713/ab.21.0371	2022	Curcumin represses lipid accumulation through inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes.	BCL2
34727830	10.1080/10428194.2021.1998480	2022	Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma.	BCL2
34728569	10.1158/1535-7163.MCT-21-0511	2022	Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.	BCL2
34730059	10.1080/08916934.2021.1995861	2022	Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway.	BCL2
34735897	10.1016/j.tranon.2021.101260	2022	A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.	BCL2
34739417	10.1097/PAS.0000000000001830	2022	Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma.	BCL2
34747234	10.1177/00031348211054526	2022	Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.	BCL2
34752896	10.1016/j.cbpc.2021.109241	2022	Excessive manganese alters serum biochemical indices, induces histopathological alterations, and activates apoptosis in liver and cerebrum of Jianzhou Da'er goat (Capra hircus).	BCL2
34756435	10.3168/jds.2021-20364	2022	Acute and chronic effects of cortisol on milk yield, the expression of key receptors, and apoptosis of mammary epithelial cells in Saanen goats.	BCL2
34764434	10.1038/s41379-021-00962-z	2022	BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis.	BCL2
34788985	10.3324/haematol.2021.279631	2022	Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing.	BCL2
34793256	10.1200/JCO.21.01194	2022	Venetoclax in Previously Treated Waldenström Macroglobulinemia.	BCL2
34795418	10.1038/s41375-021-01470-4	2022	Inhibitors of Bcl-2 and Bruton's tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models.	BCL2
34802044	10.1038/s41379-021-00954-z	2022	A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.	BCL2
34821081	10.1002/cnr2.1590	2022	Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data.	BCL2
34837284	10.1111/cas.15224	2022	Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.	BCL2
34842019	10.1080/10428194.2021.2008383	2022	Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole?	BCL2
34848360	10.1016/j.jep.2021.114873	2022	Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.	BCL2
34861556	10.1016/j.theriogenology.2021.11.017	2022	Expression of kisspeptin and its receptor in different functional classes of ovarian follicle in the buffalo (Bubalus bubalis).	BCL2
34861696	10.1182/bloodadvances.2021006211	2022	Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors.	BCL2
34864562	10.1016/j.theriogenology.2021.11.022	2022	Protegrin-1 inhibits porcine ovarian granulosa cell apoptosis from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress via the PERK/eIF2α/CHOP signaling pathway in vitro.	BCL2
34866456	10.1177/10668969211065110	2022	Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses.	BCL2
34872752	10.1016/j.pathol.2021.09.009	2022	EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements.	BCL2
34878357	10.1080/14737159.2022.2016394	2022	Association between serum concentrations of anti-apoptotic B-cell lymphoma-2 protein and traumatic brain injury mortality.	BCL2
34896653	10.1016/j.jtct.2021.12.001	2022	Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.	BCL2
34896889	10.1016/j.anndiagpath.2021.151868	2022	Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls.	BCL2
34913064	10.3892/mmr.2021.12566	2022	Substance P prevents doxorubicin‑induced cardiomyocyte injury by regulating apoptosis and autophagy: <i>In vitro</i> and <i>in vivo</i> evidence.	BCL2
34913075	10.3892/or.2021.8241	2022	Niclosamide suppresses T‑cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy.	BCL2
34913076	10.3892/ijo.2021.5292	2022	Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.	BCL2
34920187	10.1016/j.anireprosci.2021.106908	2022	Silver nanoparticles induce oxidative stress, apoptosis and impaired steroidogenesis in ovarian granulosa cells of cattle.	BCL2
34922904	10.1016/j.cbi.2021.109779	2022	Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.	BCL2
34932207	10.1007/s40265-021-01657-0	2022	Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy.	BCL2
34932406	10.1139/cjpp-2021-0596	2022	Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals.	BCL2
34932839	10.1111/and.14348	2022	Explore the effects of pulmonary fibrosis on sperm quality and the role of the PI3K/Akt pathway based on rat model.	BCL2
34937946	10.1038/s41586-021-04244-1	2022	Valine tRNA levels and availability regulate complex I assembly in leukaemia.	BCL2
34951009	10.1111/bjh.17971	2022	Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.	BCL2
34957565	10.1002/path.5861	2022	Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.	BCL2
34962105	10.1002/dc.24922	2022	Primary thyroid high-grade B-cell lymphoma with MYC and BCL2 rearrangements in Hashimoto's thyroiditis.	BCL2
34967008	10.1111/bjh.17990	2022	The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells.	BCL2
34980601	10.1158/1078-0432.CCR-21-2949	2022	Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.	BCL2
34984584	10.1007/s12035-021-02675-5	2022	Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma.	BCL2
34990302	10.1080/21655979.2021.2017590	2022	Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway.	BCL2
34994825	10.1007/s00210-021-02175-2	2022	Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways.	BCL2
34994930	10.1007/s11356-021-18399-x	2022	Histopathological, Immunohistochemical, And Molecular Alterations In Brain Tissue And Submandibular Salivary Gland Of Atrazine-Induced Toxicity In Male Rats.	BCL2
34994989	10.1002/jcla.24227	2022	Association of B-cell lymphoma 2/microRNA-497 gene expression ratio score with metastasis in patients with colorectal cancer: A propensity-matched cohort analysis.	BCL2
34999394	10.1016/j.intimp.2021.108497	2022	Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway.	BCL2
35007655	10.1016/j.dci.2022.104349	2022	SpBAG3 assisted WSSV infection in mud crab (Scylla paramamosain) by inhibiting apoptosis.	BCL2
35013138	10.1038/s41420-021-00622-w	2022	Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis.	BCL2
35028710	10.1007/s00428-021-03265-5	2022	Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.	BCL2
35030632	10.1182/bloodadvances.2021006410	2022	Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients.	BCL2
35036912	10.1177/2632010X211070774	2022	Rare but Potentially Fatal Presentations of Diffuse Large B-cell Lymphoma: Leukemic Phase or Hemophagocytic Syndrome in Bone Marrow.	BCL2
35038193	10.1111/his.14617	2022	Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort.	BCL2
35044826	10.1126/sciadv.abl4644	2022	Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma.	BCL2
35045798	10.1080/10428194.2021.2024821	2022	High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma.	BCL2
35045920	10.1691/ph.2022.1670	2022	Anti-TIM1 suppresses airway inflammation and hyperresponsiveness via the STAT6 /STAT1 pathways in mice with allergic asthma.	BCL2
35046056	10.1158/1078-0432.CCR-21-3617	2022	First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.	BCL2
35053500	10.3390/cancers14020338	2022	High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.	BCL2
35058488	10.1038/s41598-022-04916-6	2022	Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma.	BCL2
35062067	10.1016/j.biopha.2021.112601	2022	Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats.	BCL2
35064305	10.1007/s00011-021-01535-1	2022	MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6.	BCL2
35067515	10.1097/PAS.0000000000001828	2022	Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature.	BCL2
35068334	10.1080/21655979.2022.2026552	2022	Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells.	BCL2
35074718	10.1016/j.theriogenology.2022.01.017	2022	The opposite effects of VGLL1 and VGLL4 genes on granulosa cell proliferation and apoptosis of hen ovarian prehierarchical follicles.	BCL2
35076333	10.1080/10428194.2021.2010065	2022	Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression.	BCL2
35089437	10.1007/s00018-022-04139-y	2022	A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection.	BCL2
35132478	10.1007/s11064-022-03545-9	2022	Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury Model.	BCL2
35141965	10.1111/ejn.15622	2022	Sevoflurane protects mice from cerebral ischaemic injury by regulating microRNA-203-3p/HDAC4/Bcl-2 axis.	BCL2
35142981	10.1007/s11033-022-07203-9	2022	Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways.	BCL2
35151528	10.1016/j.blre.2022.100930	2022	CLL update 2022: A continuing evolution in care.	BCL2
35152630	10.3760/cma.j.cn112151-20210826-00604	2022	[Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements].	BCL2
35153031	10.1016/j.carbpol.2022.119097	2022	Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy.	BCL2
35171311	10.1007/s00277-022-04785-z	2022	CD37 expression in follicular lymphoma.	BCL2
35176466	10.1016/j.jep.2022.115095	2022	Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.	BCL2
35178927	10.19540/j.cnki.cjcmm.20210902.701	2022	[Molecular mechanism of Ganoderma against gastric cancer based on network pharmacology and experimental test].	BCL2
35183824	10.1016/j.prp.2022.153804	2022	Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma.	BCL2
35185150	10.1038/s41392-021-00870-3	2022	Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.	BCL2
35188042	10.1080/10428194.2022.2042689	2022	Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells.	BCL2
35193595	10.1186/s12943-022-01516-w	2022	BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.	BCL2
35198451	10.3389/fonc.2022.834288	2022	Prognostic Value of Radiomic Features of <sup>18</sup>F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells.	BCL2
35199915	10.1002/tox.23497	2022	Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis.	BCL2
35205731	10.3390/cancers14040983	2022	Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart.	BCL2
35217188	10.1016/j.biocel.2022.106184	2022	Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?	BCL2
35220171	10.1016/j.prp.2022.153812	2022	Prognostic value of Bcl2 and Bcl6 in primary cutaneous large B-cell lymphoma: A systematic review and meta-analysis.	BCL2
35222803	10.1155/2022/6933812	2022	Protection of Human Lens Epithelial Cells from Oxidative Stress Damage and Cell Apoptosis by KGF-2 through the Akt/Nrf2/HO-1 Pathway.	BCL2
35223094	10.1155/2022/7687154	2022	miR-197 Participates in Lipopolysaccharide-Induced Cardiomyocyte Injury by Modulating SIRT1.	BCL2
35223507	10.3389/fonc.2022.824632	2022	<i>PIM1</i> and <i>CD79B</i> Mutation Status Impacts the Outcome of Primary Diffuse Large B-Cell Lymphoma of the CNS.	BCL2
35225270	10.3791/62961	2022	Enhancing Tumor Content through Tumor Macrodissection.	BCL2
35231992	10.3760/cma.j.issn.0253-2727.2022.01.009	2022	[MYC and BCL-2 protein co-expression and prognosis of patients with diffuse large B-cell lymphoma: a propensity score matching analysis].	BCL2
35233562	10.15212/amm-2021-0002	2022	The regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's disease.	BCL2
35234557	10.1080/1354750X.2022.2048892	2022	Phytochemical constituents and protective efficacy of <i>Schefflera arboricola</i> L. leaves extract against thioacetamide-induced hepatic encephalopathy in rats.	BCL2
35236331	10.1186/s12885-022-09237-5	2022	Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma.	BCL2
35237395	10.1177/20406207221080738	2022	Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL).	BCL2
35237907	10.1007/s10930-022-10046-9	2022	Multi-catalytic Sites Inhibition of Bcl2 Induces Expanding of Hydrophobic Groove: A New Avenue Towards Waldenström Macroglobulinemia Therapy.	BCL2
35240234	10.1016/j.canlet.2022.215608	2022	DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.	BCL2
35241367	10.1016/j.semcdb.2022.01.011	2022	Mitochondrial-apoptotic signaling involvement in remodeling during myogenesis and skeletal muscle atrophy.	BCL2
35255774	10.1080/15548627.2022.2048432	2022	TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss.	BCL2
35256453	10.1523/ENEURO.0434-21.2022	2022	Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway.	BCL2
35266562	10.1002/ajh.26523	2022	Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments.	BCL2
35276693	10.1097/CAD.0000000000001282	2022	LncRNA ZFPM2-AS1 drives the progression of nasopharyngeal carcinoma via modulating the downstream miR-3612/DTL signaling.	BCL2
35277463	10.1136/jitc-2020-002029corr1	2022	Correction: MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.	BCL2
35277788	10.1007/s11033-022-07221-7	2022	The relationship between B-cell lymphoma 2, interleukin-1β, interleukin-17, and interleukin-33 and the development of diabetic nephropathy.	BCL2
35279534	10.1016/j.theriogenology.2022.02.028	2022	Ascorbic acid regulates mouse spermatogonial stem cell proliferation in a Wnt/β-catenin/ROS signaling dependent manner.	BCL2
35286779	10.1002/jez.2592	2022	Effects of metformin on the uterus of d-galactose-induced aging mice: Histomorphometric, immunohistochemical localization (B-cell lymphoma 2, Bcl2-associated X protein, and active capase3), and oxidative stress study.	BCL2
35292420	10.1016/j.jphotobiol.2022.112426	2022	Blue light induces skin apoptosis and degeneration through activation of the endoplasmic reticulum stress-autophagy apoptosis axis: Protective role of hydrogen sulfide.	BCL2
35296646	10.1038/s41419-022-04684-1	2022	Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.	BCL2
35297566	10.1111/pin.13223	2022	Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.	BCL2
35299080	10.1016/j.anndiagpath.2022.151913	2022	HIV-associated DLBCL: Clinicopathological factors including dual-colour chromogenic in situ hybridisation to assess MYC gene copies.	BCL2
35303910	10.1186/s13045-022-01249-9	2022	Altered pathways and targeted therapy in double hit lymphoma.	BCL2
35308723	10.7759/cureus.22023	2022	Conjunctival Pediatric-Type Follicular Lymphoma in a Young Male: A Case Report and Literature Review.	BCL2
35313087	10.1111/cbdd.14041	2022	Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.	BCL2
35316462	10.1007/s11064-022-03544-w	2022	Transcription Factor HEY1 Improves Brain Vascular Endothelial Cell Function and Alleviates Ischemic Stroke by Upregulating NOTCH3.	BCL2
35317444	10.3892/etm.2022.11208	2022	Effects and early diagnostic value of lncRNA H19 on sepsis-induced acute lung injury.	BCL2
35320477	10.1007/s11356-022-19747-1	2022	Anticolitic activity of prodigiosin loaded with selenium nanoparticles on acetic acid-induced colitis in rats.	BCL2
35321563	10.1161/ATVBAHA.121.317018	2022	Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis.	BCL2
35322932	10.1002/cam4.4692	2022	Patient-reported outcomes provide prognostic information for survival in patients with diffuse large B-cell lymphoma: Analysis of 1239 patients from the GOYA study.	BCL2
35324708	10.3390/toxins14030211	2022	Protective Effects of Taraxasterol against Deoxynivalenol-Induced Damage to Bovine Mammary Epithelial Cells.	BCL2
35331723	10.1016/j.ejphar.2022.174907	2022	Novel vandetanib derivative inhibited proliferation and promoted apoptosis of cancer cells under normoxia and hypoxia.	BCL2
35339405	10.1016/j.clml.2022.02.005	2022	SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia.	BCL2
35344084	10.1007/s00404-022-06531-2	2022	Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.	BCL2
35346194	10.1186/s12951-022-01377-x	2022	Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer.	BCL2
35347000	10.21873/anticanres.15658	2022	Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies.	BCL2
35350909	10.1177/10781552221090869	2022	Real-world management of targeted therapies in chronic lymphocytic leukemia.	BCL2
35365988		2022	[Protective effect of nuclear receptor related 1 (Nurr1) on nerves in rats with cerebral occlusion/reperfusion injury and its mechanism].	BCL2
35365989		2022	[Inhibition of autophagy enhances apoptosis induced by doxorubicin hydrochloride in human colon cancer cells].	BCL2
35366141	10.1007/s10495-022-01723-2	2022	Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.	BCL2
35368047	10.1038/s41375-022-01556-7	2022	Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).	BCL2
35370290	10.1038/s41392-022-00915-1	2022	Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies.	BCL2
35371331	10.7150/jca.69639	2022	Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma.	BCL2
35379357	10.1186/s40364-022-00357-5	2022	Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma.	BCL2
35381283	10.1016/j.ijbiomac.2022.03.212	2022	Molecular characterization, expression and anti-tumor function analysis of yak IFITM2 gene.	BCL2
35393909	10.1080/09513590.2022.2061454	2022	Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls.	BCL2
35411095	10.1038/s41375-022-01558-5	2022	JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.	BCL2
35414044	10.1186/s13287-022-02832-0	2022	Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.	BCL2
35414839		2022	Primary ovarian Burkitt lymphoma: report of a case and review of literature.	BCL2
35422931		2022	HGF induces oncoprotein HCCR-1 expression through the Wnt/β-catenin pathway in gastric cancer.	BCL2
35425994	10.3892/mmr.2022.12710	2022	Preparation of Nereid oligopeptide and investigation of the mechanism underlying the induction of apoptosis in human lung cancer H1299 cells.	BCL2
35432742	10.4253/wjge.v14.i3.176	2022	Mucosa-associated lymphoid tissue lymphoma in the terminal ileum: A case report.	BCL2
35435120	10.1080/21655979.2022.2061283	2022	CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression.	BCL2
35435617	10.1007/s11864-022-00953-5	2022	Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T.	BCL2
35436854	10.1186/s12863-022-01041-1	2022	An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.	BCL2
35444774	10.4084/MJHID.2022.018	2022	TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.	BCL2
35448884	10.3390/toxins14040275	2022	Protective Effects of Ferulic Acid on Deoxynivalenol-Induced Toxicity in IPEC-J2 Cells.	BCL2
35452696	10.1016/j.humpath.2022.04.002	2022	B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas.	BCL2
35468679	10.31083/j.fbl2704120	2022	Phytochemical Profiling of Microalgae <i>Euglena tuba</i> and Its Anticancer Activity in Dalton's Lymphoma Cells.	BCL2
35481444	10.1080/10428194.2022.2064988	2022	Impact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation.	BCL2
35482553	10.1002/hon.3010	2022	Targeting MYC and BCL2 by a natural compound for ""double-hit"" lymphoma.	BCL2
35483927	10.5045/br.2022.2022037	2022	Basic immunohistochemistry for lymphoma diagnosis.	BCL2
35484682	10.3324/haematol.2021.280557	2022	Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement.	BCL2
35489963	10.1016/j.blre.2022.100967	2022	ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma.	BCL2
35495111	10.1016/j.csbj.2022.03.023	2022	Integrating whole genome sequencing, methylation, gene expression, topological associated domain information in regulatory mutation prediction: A study of follicular lymphoma.	BCL2
35498426	10.3389/fendo.2022.846357	2022	Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.	BCL2
35504024	10.18632/aging.204041	2022	<i>In vitro</i> and <i>in vivo</i> anti-lymphoma effects of <i>Ophiorrhiza pumila</i> extract.	BCL2
35510016	10.7759/cureus.23681	2022	Incidental Pathogenic Fibrin-Associated Diffuse Large B-cell Lymphoma Found During Aorto-Biiliac Bypass.	BCL2
35511481	10.1080/09553002.2022.2074164	2022	<i>BAG1, MGMT, FOXO1</i>, and <i>DNAJA1</i> as potential drug targets for radiosensitizing cancer cell lines.	BCL2
35511691	10.1093/ajcp/aqac047	2022	A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.	BCL2
35513284	10.1016/j.mce.2022.111653	2022	Exosomal miR-140-3p and miR-143-3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis.	BCL2
35535226	10.1155/2022/1565094	2022	Analysis of the Role and Mechanism of ZEB1 in Regulating Cervical Carcinoma Progression via Modulating PD-1/PD-L1 Checkpoint.	BCL2
35538643	10.1002/cam4.4742	2022	Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.	BCL2
35539018	10.1016/j.lrr.2022.100318	2022	A very rare case of extranodal B-cell non-Hodgkin lymphoma presenting with adrenal and heart involvement.	BCL2
35549669	10.1164/rccm.202201-0033OC	2022	Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs.	BCL2
35566180	10.3390/molecules27092827	2022	Dioscin-Mediated Autophagy Alleviates MPP<sup>+</sup>-Induced Neuronal Degeneration: An In Vitro Parkinson's Disease Model.	BCL2
35568724	10.1038/s41394-022-00520-y	2022	Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report.	BCL2
35571331	10.1016/j.fochx.2022.100322	2022	Recent developments in <i>Moringa oleifera</i> Lam. polysaccharides: A review of the relationship between extraction methods, structural characteristics and functional activities.	BCL2
35571440	10.21037/atm-22-894	2022	Long non-coding RNA MEG3 regulates the progress of osteoarthritis by regulating the miR-34a/Klotho axis.	BCL2
35576104	10.1111/1440-1681.13667	2022	Glaucocalyxin A induces apoptosis of non-small cell lung carcinoma cells by inhibiting the PI3K/Akt/GSK3β pathway.	BCL2
35576884	10.1016/j.jinorgbio.2022.111855	2022	Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.	BCL2
35577753	10.1016/j.clml.2022.04.017	2022	SOHO State of the Art Updates and Next Questions | Management of Most Difficult Cases of Chronic Lymphocytic Leukemia: Relapse After Both BTK and BCL2 Inhibition and Richter Transformation.	BCL2
35578798	10.1002/jcp.30777	2022	Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells.	BCL2
35583405	10.1097/DAD.0000000000002053	2022	Histological Transformation and Clonal Relationship of Subcutaneous Marginal Zone B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma.	BCL2
35583555	10.1158/1078-0432.CCR-21-3811	2022	VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.	BCL2
35583809	10.1002/ptr.7481	2022	Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6/Axl signaling.	BCL2
35584731	10.1016/j.tiv.2022.105386	2022	Paclitaxel is evidence to reduce growing ovarian follicle growth in mice model study.	BCL2
35592654	10.1155/2022/5707504	2022	Effect of miR-144-3p-Targeted Regulation of PTEN on Proliferation, Apoptosis, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells under Stretch.	BCL2
35595618	10.1016/j.clml.2022.04.010	2022	Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.	BCL2
35601256	10.1016/j.aninu.2022.03.003	2022	Effects of fish meal replacement with <i>Chlorella</i> meal on growth performance, pigmentation, and liver health of largemouth bass (<i>Micropterus salmoides</i>).	BCL2
35603649		2022	[Activation of JNK induces apoptosis to autophagy conversion and enhances the survival of oxygen-glycogen deprived rat neurons].	BCL2
35603962	10.1002/mgg3.1964	2022	Construction of three-gene-based prognostic signature and analysis of immune cells infiltration in children and young adults with B-acute lymphoblastic leukemia.	BCL2
35610180	10.1002/cbdv.202100845	2022	Co-Binding of JQ1 and Venetoclax Exhibited Synergetic Inhibitory Effect for Cancer Therapy; Potential Line of Treatment for the Waldenström Macroglobulinemia Lymphoma.	BCL2
35616841	10.1007/s11356-022-20734-9	2022	Cadmium induces apoptosis by miR-9-5p targeting PTEN and regulates the PI3K/AKT pathway in the piglet adrenal gland.	BCL2
35621073	10.1039/d1fo03746c	2022	Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status.	BCL2
35622324	10.1007/978-1-0716-2115-8_8	2022	Targeted Locus Amplification as Marker Screening Approach to Detect Immunoglobulin (IG) Translocations in B-Cell Non-Hodgkin Lymphomas.	BCL2
35624736	10.3390/antiox11050872	2022	Dietary Tryptophan Supplementation Improves Antioxidant Status and Alleviates Inflammation, Endoplasmic Reticulum Stress, Apoptosis, and Pyroptosis in the Intestine of Piglets after Lipopolysaccharide Challenge.	BCL2
35625017	10.3390/brainsci12050631	2022	Preconditioned MSCs Alleviate Cerebral Ischemia-Reperfusion Injury in Rats by Improving the Neurological Function and the Inhibition of Apoptosis.	BCL2
35633553	10.31557/APJCP.2022.23.5.1679	2022	Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.	BCL2
35635742	10.1177/10781552221103820	2022	Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia.	BCL2
35640776	10.1016/j.lfs.2022.120675	2022	Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.	BCL2
35646671	10.3389/fonc.2022.883141	2022	Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature.	BCL2
35652622	10.4149/neo_2022_220318N300	2022	High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry.	BCL2
35653936	10.1016/j.jtemb.2022.127014	2022	Up-regulation of B-cell lymphoma factor-2 expression, inhibition of oxidative stress and down-regulation of pro-inflammatory cytokines are involved in the protective effect of cabbage (Brassica oleracea) juice in lead-induced endothelial dysfunction in rats.	BCL2
35657404	10.1007/s00428-022-03342-3	2022	Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.	BCL2
35659041	10.1186/s13045-022-01295-3	2022	Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination.	BCL2
35661922	10.1007/s00428-022-03347-y	2022	H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.	BCL2
35662912	10.1155/2022/9569226	2022	Nanoemulsion and Encapsulation Strategy of Hydrophobic Oregano Essential Oil Increased Human Prostate Cancer Cell Death via Apoptosis by Attenuating Lipid Metabolism.	BCL2
35673965	10.1002/1878-0261.13264	2022	The SKP2-p27 axis defines susceptibility to cell death upon CHK1 inhibition.	BCL2
35674932	10.1007/s12105-022-01461-6	2022	Extranodal MALT Lymphoma in the Oral Cavity: A Series of Three Cases with Review of Literature.	BCL2
35678255	10.1111/jcmm.17358	2022	LncRNA SNHG1 promotes sepsis-induced myocardial injury by inhibiting Bcl-2 expression via DNMT1.	BCL2
35685242	10.3389/fmolb.2022.864874	2022	Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated Perspective.	BCL2
35687213	10.1007/s10753-022-01696-z	2022	PTX3 Protects Intestinal Mucosal Barrier Damage in Sepsis Through Toll-Like Receptor Signaling Pathway.	BCL2
35701534	10.1038/s41388-022-02372-0	2022	BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma.	BCL2
35704690	10.1182/blood.2021014304	2022	Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies.	BCL2
35705274	10.2169/internalmedicine.9711-22	2022	Biclonal diffuse large B-cell lymphoma commonly characterized by partial trisomy 18q involving MALT1 and BCL2.	BCL2
35709931	10.1016/j.drudis.2022.06.002	2022	BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics.	BCL2
35715938	10.1002/cjp2.283	2022	Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit/triple-hit genotype and survival in diffuse large B-cell lymphoma.	BCL2
35716968	10.1016/j.fsi.2022.06.017	2022	Dietary chlorella (Chlorella vulgaris) supplementation effectively improves body color, alleviates muscle inflammation and inhibits apoptosis in largemouth bass (Micropterus salmoides).	BCL2
35749795	10.1097/MCP.0000000000000879	2022	Senescence in pulmonary arterial hypertension: is there a link?	BCL2
35759728	10.1182/blood.2022015926	2022	Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.	BCL2
35760783	10.1038/s41419-022-05021-2	2022	IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma.	BCL2
35762155	10.1080/10520295.2022.2083685	2022	Effects of long term diabetogenic high fat diet on bone in ovariectomized female rats.	BCL2
35770040	10.2147/TCRM.S338655	2022	Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First.	BCL2
35774514	10.3389/fgene.2022.827840	2022	A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.	BCL2
35782651	10.1093/toxres/tfac024	2022	Isorhamnetin: a flavonoid, attenuated doxorubicin-induced testicular injury via regulation of steroidogenic enzymes and apoptotic signaling gene expression in male rats.	BCL2
35783530	10.1155/2022/9100056	2022	LINC00461 Regulates the Recurrence of Large B Cell Lymphoma through the miR-411-5p/BNIP3 Pathway.	BCL2
35787399	10.1016/j.jid.2022.06.005	2022	The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.	BCL2
35792817	10.1080/10790268.2022.2088498	2022	Warm acupuncture therapy alleviates neuronal apoptosis after spinal cord injury via inhibition of the ERK signaling pathway.	BCL2
35794096	10.1038/s41467-022-31355-8	2022	Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.	BCL2
35794478	10.1038/s41586-022-04906-8	2022	Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.	BCL2
35795062	10.3389/fonc.2022.870487	2022	Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis.	BCL2
35800619	10.1016/j.bbrep.2022.101303	2022	CA10 is associated with HBV-related hepatocarcinogenesis.	BCL2
35804999	10.3390/cancers14133229	2022	Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma.	BCL2
35816682	10.1182/bloodadvances.2022008355	2022	Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III/IV.	BCL2
35830966	10.1111/ijlh.13928	2022	Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression.	BCL2
35846201	10.1002/jha2.310	2022	Redefining the high-grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report.	BCL2
35846216	10.1002/jha2.364	2022	Primary cutaneous diffuse large B-cell lymphoma, leg type with <i>MYC/BCL2/BCL6</i> overexpression.	BCL2
35847946	10.3389/fonc.2022.864430	2022	Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia.	BCL2
35848706	10.4103/aja202242	2022	The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction.	BCL2
35851082		2022	[Paeoniflorin inhibits Wnt1/β-catenin pathway and promotes apoptosis of fibroblast-like synoviocytes in patients with rheumatoid arthritis by upregulating lncRNA MALAT1].	BCL2
35856441	10.3892/or.2022.8375	2022	Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.	BCL2
35857625	10.1126/scitranslmed.abl5654	2022	Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy.	BCL2
35857791	10.1080/15548627.2022.2100105	2022	Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis.	BCL2
35861049	10.1002/jsfa.12141	2022	Research on apoptotic mechanism and related pathways involving in postmortem grass carp (Ctenopharyngodon idellus) muscle.	BCL2
35869021	10.1016/j.clml.2022.06.011	2022	Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.	BCL2
35879400	10.1038/s41598-022-16943-4	2022	Promising anti-leukemic effect of Zataria multiflora extract in combination with doxorubicin to combat acute lymphoblastic leukemia cells (Nalm-6) (in vitro and in silico).	BCL2
35884496	10.3390/cancers14143434	2022	Classifying Germinal Center Derived Lymphomas-Navigate a Complex Transcriptional Landscape.	BCL2
35885931	10.3390/genes13071144	2022	Targeting a Novel G-Quadruplex in the <i>CARD11</i> Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group.	BCL2
35893891	10.3390/nu14153037	2022	Shibi Tea (<i>Adinandra nitida</i>) and Camellianin A Alleviate CCl<sub>4</sub>-Induced Liver Injury in C57BL-6J Mice by Attenuation of Oxidative Stress, Inflammation, and Apoptosis.	BCL2
35900563	10.4103/jcrt.JCRT_676_19	2022	Signet ring cell lymphoma of follicular type with BCL2 gene rearrangement: A rare case with a short review of literature.	BCL2
35916333	10.1002/dc.25027	2022	HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.	BCL2
35916644	10.1097/QAI.0000000000003069	2022	Diffuse Large B-cell Lymphoma in the public-sector of Johannesburg, South Africa, in the era of widescale Anti-retroviral therapy use.	BCL2
35919815	10.7150/ijms.73077	2022	[6]-Gingerol induces Caspase-Dependent Apoptosis in Bladder Cancer cells via MAPK and ROS Signaling.	BCL2
35920412	10.1002/jbt.23185	2022	Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro.	BCL2
35932211	10.1002/hon.3061	2022	Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.	BCL2
35933930	10.1016/j.ctrv.2022.102443	2022	Treatment strategies for patients with diffuse large B-cell lymphoma.	BCL2
35936524	10.18502/ijph.v51i4.9251	2022	The Effect of <i>B-Cell Lymphoma 2</i> and <i>BCL2-Associated X</i> Polymorphisms on the Survival of Acute Lymphoblastic Leukemia Patients: Application of Frailty Survival Models.	BCL2
35952327	10.1200/JCO.22.00597	2022	Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.	BCL2
35953760	10.1631/jzus.B2200016	2022	HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression.	BCL2
35955467	10.3390/ijms23158334	2022	Synovial Fluid Regulates the Gene Expression of a Pattern of microRNA via the NF-κB Pathway: An In Vitro Study on Human Osteoarthritic Chondrocytes.	BCL2
35962819	10.1007/s00280-022-04460-0	2022	Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.	BCL2
35968590	10.3760/cma.j.issn.0253-2727.2022.06.006	2022	[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review].	BCL2
35970756	10.1016/j.clml.2022.07.013	2022	Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukaemia and Potential Future Therapeutic Directions.	BCL2
35974958	10.1097/HS9.0000000000000767	2022	Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.	BCL2
35979721	10.3324/haematol.2022.280631	2022	Selective inhibition of MCL1 overcomes venetoclax-resistance in a murine model of myelodysplastic syndromes.	BCL2
35982976	10.3389/fonc.2022.934008	2022	Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation.	BCL2
35983732	10.1080/10428194.2022.2098291	2022	Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL.	BCL2
36001789	10.46883/2022.25920970	2022	Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas.	BCL2
36014833	10.3390/nu14163327	2022	The Protective Effect of α-Lipoic Acid against Gold Nanoparticles (AuNPs)-Mediated Liver Damage Is Associated with Upregulating Nrf2 and Suppressing NF-κB.	BCL2
36029292	10.1111/bcpt.13788	2022	The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1α/miR-143 signalling.	BCL2
36035812	10.1016/j.jobcr.2022.07.009	2022	Expression and bioinformatics analyses show HSP70 complements BCL2 action in oral carcinogenesis.	BCL2
36048893	10.1093/ajcp/aqac104	2022	Systemic Presentation of Somatic TET2 Mutated B-Cell Lymphoma in a Child With Kabuki Syndrome and a Germline KMT2D Variant.	BCL2
36051027	10.1002/jha2.489	2022	Inactivating <i>BTK</i> mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with <i>BCL2</i> translocation.	BCL2
36051039	10.1002/jha2.513	2022	Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement.	BCL2
36051055	10.1002/jha2.457	2022	An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.	BCL2
36054886	10.1097/SCS.0000000000008519	2022	Influence of Experimental Skull Defects on Brain.	BCL2
36056803	10.1111/and.14579	2022	Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis.	BCL2
36057749	10.1007/s00428-022-03404-6	2022	Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.	BCL2
36062172	10.1155/2022/1932777	2022	Ethyl Acetate Fraction of <i>Hedyotis diffusa Willd</i> Induces Apoptosis via JNK/Nur77 Pathway in Hepatocellular Carcinoma Cells.	BCL2
36081566	10.3389/fonc.2022.941347	2022	Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx.	BCL2
36082710		2022	[Homocysteine induces glomerular podocyte apoptosis via up-regulation of miR-488-3p expression in MPC-5 mice].	BCL2
36092159	10.1155/2022/3737137	2022	Ginsenoside Rg1 Ameliorates Acute Renal Ischemia/Reperfusion Injury via Upregulating AMPK<i>α</i>1 Expression.	BCL2
36092554	10.1021/acsomega.2c02796	2022	Lycopene Effects on Metabolic Syndrome and Kidney Injury in Rats Fed a High-Fat Diet: An Experimental Study.	BCL2
36098711	10.1111/cbdd.14144	2022	The expression of miR-181b, CYLD, CBX-7, BCL2, and p53 in osteosarcoma patients and correlation with clinicopathological factors.	BCL2
36100068	10.1016/j.fsi.2022.09.005	2022	Molecular characterization and expression analysis of B-cell lymphoma-2 protein in Amphiprion clarkii and its role in virus infections.	BCL2
32515262	10.1089/neu.2020.7028	2021	B-Cell Lymphoma 2 (Bcl-2) Gene Is Associated with Intracranial Hypertension after Severe Traumatic Brain Injury.	BCL2
32749680	10.1002/jcp.29943	2021	Light-emitting diode irradiation induces AKT/mTOR-mediated apoptosis in human pancreatic cancer cells and xenograft mouse model.	BCL2
32912960	10.1136/jclinpath-2020-206767	2021	<i>BCL2</i> and <i>BCL6</i> atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course.	BCL2
33120427	10.1182/blood.2020007193	2021	The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.	BCL2
33356554	10.2217/epi-2020-0189	2021	Epigenetic targeting of Waldenström macroglobulinemia cells with BET inhibitors synergizes with BCL2 or histone deacetylase inhibition.	BCL2
33423045	10.1038/s41419-020-03311-1	2021	GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner.	BCL2
33480087	10.1002/hon.2839	2021	High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup.	BCL2
33495811	10.3892/ijmm.2021.4858	2021	Effects of Smad4 on the expression of caspase‑3 and Bcl‑2 in human gingival fibroblasts cultured on 3D PLGA scaffolds induced by compressive force.	BCL2
33580459	10.1007/s11033-021-06161-y	2021	Increased level of long non coding RNA H19 is correlated with the downregulation of miR-326 and BCL-2 genes in pediatric acute lymphoblastic leukemia, a possible hallmark for leukemogenesis.	BCL2
33605072	10.1111/jcmm.16373	2021	Cyclic stretching boosts microRNA-499 to regulate Bcl-2 via microRNA-208a in atrial fibroblasts.	BCL2
33689920	10.1016/j.leukres.2021.106552	2021	Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.	BCL2
33799592	10.3390/ijms22062841	2021	Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer.	BCL2
33858042	10.3760/cma.j.issn.0253-2727.2021.02.006	2021	[The incidence of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in diffuse large B-cell lymphoma].	BCL2
33910828	10.21873/invivo.12403	2021	Depletion of NK Cells Resistant to Ionizing Radiation Increases Mutations in Mice After Whole-body Irradiation.	BCL2
33912159	10.3389/fimmu.2021.627602	2021	The <i>Traf2</i>DNx<i>BCL2-tg</i> Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart.	BCL2
33912563	10.3389/fcell.2021.647522	2021	Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development.	BCL2
33914737	10.1371/journal.pone.0237830	2021	Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice.	BCL2
33917107	10.3390/ijms22083829	2021	Quercetin Attenuates Brain Oxidative Alterations Induced by Iron Oxide Nanoparticles in Rats.	BCL2
33934404	10.1002/jcla.23784	2021	PCR array analysis identified hyperproliferation but not autophagy or apoptosis in fibrous epulis.	BCL2
33938687	10.36849/JDD.5373	2021	A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor.	BCL2
33938816	10.4103/CJP.CJP_79_20	2021	Tau phosphorylation and cochlear apoptosis cause hearing loss in 3×Tg-AD Mouse Model of Alzheimer's Disease.	BCL2
33939407	10.1021/acs.jmedchem.0c02200	2021	Pharmacological Targeting of Executioner Proteins: Controlling Life and Death.	BCL2
33945543	10.1371/journal.pone.0248886	2021	Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.	BCL2
33946435	10.3390/cancers13092167	2021	Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma.	BCL2
33955654	10.1111/jcmm.16558	2021	Exosomes derived from MSC pre-treated with oridonin alleviates myocardial IR injury by suppressing apoptosis via regulating autophagy activation.	BCL2
33959502	10.3389/fonc.2021.638897	2021	c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study.	BCL2
33962620	10.1186/s12957-021-02216-3	2021	A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2.	BCL2
33964277	10.1016/j.humpath.2021.04.014	2021	Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.	BCL2
33973992		2021	Cryopreservation of Dog Spermatozoa Using Essential and Non-Essential Amino Acids Solutions in An Egg Yolk-Free Polyvinyl Alcohol Extender.	BCL2
33974882	10.1016/j.ejphar.2021.174167	2021	Effects of trans-resveratrol on type 1 diabetes-induced up-regulation of apoptosis and mitogen-activated protein kinase signaling in retinal pigment epithelium of Dark Agouti rats.	BCL2
33978190	10.1093/jn/nxab116	2021	Dietary n-3 PUFA Deficiency Increases Vulnerability to Scopolamine-Induced Cognitive Impairment in Male C57BL/6 Mice.	BCL2
33980772	10.1507/endocrj.EJ20-0739	2021	Circular RNA circ_0000712 regulates high glucose-induced apoptosis, inflammation, oxidative stress, and fibrosis in (DN) by targeting the miR-879-5p/SOX6 axis.	BCL2
33988072	10.1080/10428194.2021.1927020	2021	Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with <i>MYC</i> and <i>MYC</i>/<i>BCL2</i> rearrangements, especially in germinal center cell-type tumors.	BCL2
33997750	10.1016/j.jhepr.2021.100276	2021	Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.	BCL2
34007050	10.1038/s41375-021-01291-5	2021	MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.	BCL2
34007370	10.14740/jh818	2021	<i>MYC</i>-Positive Diffuse Large B-Cell Lymphoma in Leukemic Phase at Presentation: A Diagnostic and Therapeutic Challenge.	BCL2
34012033	10.1038/s41416-021-01434-6	2021	A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.	BCL2
34012594	10.21037/jtd-21-551	2021	Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4.	BCL2
34017010	10.1038/s41597-021-00915-w	2021	DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set.	BCL2
34027047	10.1080/23723556.2021.1911290	2021	The importance of transmembrane domain interactions in the viral control of apoptosis.	BCL2
34027766	10.1080/08916934.2021.1919878	2021	MiR-429 prohibited NF-κB signalling to alleviate contrast-induced acute kidney injury via targeting PDCD4.	BCL2
34031842	10.1007/s11064-021-03353-7	2021	The Effect of NeuroAid (MLC901) on Cholestasis-Induced Spatial Memory Impairment with Respect to the Expression of BAX, BCL-2, BAD, PGC-1α and TFAM Genes in the Hippocampus of Male Wistar Rats.	BCL2
34044633	10.1177/03000605211019187	2021	Association of <i>BCL2</i> polymorphisms and the <i>IL19</i> single nucleotide polymorphism rs2243188 with systemic lupus erythematosus.	BCL2
34046322		2021	Cytotoxic effects of hydroalcoholic extract of <i>Cuscuta chinensis</i> on PC3 and MCF7 cancer cell lines.	BCL2
34051685	10.1016/j.ejrad.2021.109784	2021	Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.	BCL2
34059487	10.1016/j.clml.2021.04.004	2021	A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.	BCL2
34060449		2021	[Chronic venous disease increases placental villous angiogenesis and lymphangiogenesis and villous cell apoptosis].	BCL2
34061027	10.7554/eLife.67336	2021	Contingency and chance erase necessity in the experimental evolution of ancestral proteins.	BCL2
34078654	10.1136/jitc-2020-002029	2021	MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.	BCL2
34097157	10.1007/s11864-021-00857-w	2021	Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.	BCL2
34099597	10.4014/jmb.2102.02010	2021	LINC01272 Suppressed Cell Multiplication and Induced Apoptosis Via Regulating MiR-7-5p/CRLS1 Axis in Lung Cancer.	BCL2
34101913	10.1111/jop.13208	2021	Prognostic significance of CD30 expression in diffuse large B-cell lymphoma: A systematic review with meta-analysis.	BCL2
34105411	10.1177/15347354211021920	2021	Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice.	BCL2
34105893	10.1002/cam4.4062	2021	Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.	BCL2
34106911		2021	Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?	BCL2
34107971	10.1186/s13018-021-02504-4	2021	Raloxifene retards the progression of adjacent segmental intervertebral disc degeneration by inhibiting apoptosis of nucleus pulposus in ovariectomized rats.	BCL2
34113336	10.3389/fimmu.2021.599493	2021	<i>PiggyBac</i>-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report.	BCL2
34123811	10.3389/fonc.2021.656219	2021	Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma.	BCL2
34139193	10.1016/j.ajpath.2021.06.004	2021	Rictor/Mammalian Target of Rapamycin Complex 2 Signaling Protects Colonocytes from Apoptosis and Prevents Epithelial Barrier Breakdown.	BCL2
34151288	10.1038/s43018-020-00167-4	2021	Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.	BCL2
34159086	10.21037/tau-21-280	2021	The protective effects of exogenous spermine on renal ischemia-reperfusion injury in rats.	BCL2
34165702	10.1007/s12282-021-01266-5	2021	Biology of primary breast cancer in older women beyond routine biomarkers.	BCL2
34166762	10.1016/j.neuroscience.2021.06.021	2021	Phosphatase and Tensin Homolog Deleted on Chromosome Ten Knockdown Attenuates Cognitive Deficits by Inhibiting Neuroinflammation in a Mouse Model of Perioperative Neurocognitive Disorder.	BCL2
34171161	10.1111/pin.13131	2021	Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large B-cell lymphoma.	BCL2
34174694	10.1016/j.jss.2021.05.004	2021	Sulforaphane Ameliorates the Liver Injury of Traumatic Hemorrhagic Shock Rats.	BCL2
34176492	10.1186/s13256-021-02949-5	2021	A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report.	BCL2
34178461	10.7717/peerj.11577	2021	Expression of autophagy and apoptosis-related factors in the periodontal tissue of experimental diabetic rats: a histomorphometric, microtomographic and immunohistochemical study.	BCL2
34180401	10.14411/fp.2021.016	2021	Toxoplasma gondii ROP17 promotes autophagy via the Bcl-2-Beclin 1 pathway.	BCL2
34185336	10.1002/ajh.26284	2021	BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.	BCL2
34199936	10.3390/ijms22116084	2021	Suppression of TRPV1/TRPM8/P2Y Nociceptors by Withametelin via Downregulating MAPK Signaling in Mouse Model of Vincristine-Induced Neuropathic Pain.	BCL2
34202528	10.3390/cancers13133155	2021	Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types.	BCL2
34204385	10.3390/cancers13123032	2021	Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing.	BCL2
34210682	10.1158/1078-0432.CCR-21-0553	2021	Network Analysis Reveals Synergistic Genetic Dependencies for Rational Combination Therapy in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia.	BCL2
34219464	10.1139/bcb-2021-0045	2021	Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.	BCL2
34221962	10.3389/fonc.2021.638154	2021	Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.	BCL2
34224392	10.1530/REP-21-0157	2021	PIWIs maintain testis apoptosis to remove abnormal germ cells in Eriocheir sinensis.	BCL2
34226167	10.1016/j.clml.2021.05.018	2021	Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.	BCL2
34243771	10.1186/s12958-021-00791-4	2021	Characterization of the effects of heat stress on autophagy induction in the pig oocyte.	BCL2
34251414	10.1182/bloodadvances.2021004233	2021	Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).	BCL2
34259934	10.1007/s12032-021-01513-x	2021	Computational study on novel natural inhibitors targeting BCL2.	BCL2
34269703	10.1097/FJC.0000000000001031	2021	Circ-PRKCI Alleviates Lipopolysaccharide-induced Human Kidney 2 Cell Injury by Regulating miR-106b-5p/GAB1 Axis.	BCL2
34272731	10.1111/bjh.17708	2021	EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.	BCL2
34276389	10.3389/fphys.2021.603848	2021	Expression of Autophagy-Related Factors LC3A and Beclin 1 and Apoptosis-Related Factors Bcl-2 and BAX in Osteoblasts Treated With Sodium Fluoride.	BCL2
34277781	10.21037/atm-21-2574	2021	A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway.	BCL2
34282785	10.3390/cancers13133367	2021	Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.	BCL2
34282799	10.3390/cancers13133369	2021	The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.	BCL2
34284777	10.1186/s12958-021-00799-w	2021	Effects of low intensity pulsed ultrasound on expression of B-cell lymphoma-2 and BCL2-Associated X in premature ovarian failure mice induced by 4-vinylcyclohexene diepoxide.	BCL2
34295778	10.21037/tp-21-39	2021	Effect of SOCS3 on apoptosis of human trophoblasts via adjustment of the JAK2/STAT3 signaling pathway in preterm birth.	BCL2
34295921	10.3389/fmolb.2021.681849	2021	Novel Nanoliposomes Alleviate Contrast-Induced Nephropathy by Mediating Apoptosis Response in New Zealand Rabbits.	BCL2
34302428	10.1111/jcmm.16793	2021	Novel polysaccharide extracted from Sipunculus nudus inhibits HepG2 tumour growth in vivo by enhancing immune function and inducing tumour cell apoptosis.	BCL2
34302634	10.1007/s13258-021-01142-8	2021	Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR<sub>L</sub> downregulation in Caki-1 cells.	BCL2
34307232	10.4322/acr.2021.278	2021	De novo double-hit B-cell precursor leukemia/lymphoma - an unusual presentation as peritoneal lymphomatosis.	BCL2
34313135	10.2217/fon-2021-0370	2021	Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.	BCL2
34323626	10.1080/10428194.2021.1957870	2021	TAp63 and BCL2 expression are co-affected by cell-extrinsic signals in chronic lymphocytic leukemia.	BCL2
34328190	10.3892/mmr.2021.12327	2021	Heat shock protein 70 attenuates hypoxia‑induced apoptosis of pulmonary microvascular endothelial cells isolated from neonatal rats.	BCL2
34334687	10.1097/PAS.0000000000001726	2021	High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.	BCL2
34339901	10.1016/j.clineuro.2021.106838	2021	MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: A systematic review and meta-analysis.	BCL2
34343635	10.1016/j.canlet.2021.07.045	2021	Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance.	BCL2
34346845	10.1080/21655979.2021.1950282	2021	Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.	BCL2
34353509	10.1016/j.eimce.2020.06.017	2021	Circulating Bcl-2 concentrations and septic patient mortality.	BCL2
34359500	10.3390/foods10071630	2021	Transcriptional Changes after Enniatins A, A1, B and B1 Ingestion in Rat Stomach, Liver, Kidney and Lower Intestine.	BCL2
34369229	10.1080/10428194.2021.1957873	2021	Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells.	BCL2
34374220	10.1002/cjp2.223	2021	c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.	BCL2
34378195	10.1111/bjh.17765	2021	Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.	BCL2
34380369	10.1080/10428194.2021.1964021	2021	Whole genome sequencing demonstrates substantial pathophysiological differences of <i>MYC</i> rearrangements in patients with plasma cell myeloma and B-cell lymphoma.	BCL2
34382859	10.1089/jmf.2021.K.0059	2021	Ginkgolic Acid Suppresses Nasopharyngeal Carcinoma Growth by Inducing Apoptosis and Inhibiting <i>AKT/NF-κB</i> Signaling.	BCL2
34384155	10.3760/cma.j.issn.0253-2727.2021.06.008	2021	[Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma].	BCL2
34386317	10.1016/j.apsb.2020.10.018	2021	Natural compounds modulate the autophagy with potential implication of stroke.	BCL2
34388250	10.1093/jnen/nlab080	2021	Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.	BCL2
34389272	10.1016/j.clml.2021.07.012	2021	SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AML.	BCL2
34400859	10.1016/j.jsps.2021.04.027	2021	Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets.	BCL2
34400968	10.22037/ijpr.2019.14907.12738	2021	Evaluation of Nrf2, Keap1 and Apoptotic Pathway Genes Expression in Acute Myeloid Leukemia Patients.	BCL2
34402163	10.1111/jcmm.16822	2021	BAG1 down-regulation increases chemo-sensitivity of acute lymphoblastic leukaemia cells.	BCL2
34404436	10.1186/s13027-021-00396-x	2021	Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China.	BCL2
34406351	10.1093/ajcp/aqab043	2021	Light Chain-Restricted Plasmacytoid Cells in Hyperplastic Germinal CentersA Clinicopathologic Investigation.	BCL2
34406846	10.1089/gtmb.2021.0009	2021	<i>miR-1</i> Targeted Downregulation of <i>Bcl-2</i> Increases Chemosensitivity of Lung Cancer Cells.	BCL2
34417162	10.1016/j.clml.2021.07.016	2021	A Phase 2 Study of PNT2258 for Treatment of Relapsed or Refractory B-Cell Malignancies.	BCL2
34424320	10.1182/bloodadvances.2020003276	2021	The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.	BCL2
34424958	10.1182/blood.2021012052	2021	Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.	BCL2
34425193	10.1016/j.ijpharm.2021.121034	2021	Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis.	BCL2
34438040	10.1016/j.annonc.2021.08.1991	2021	SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status.	BCL2
34438219	10.1016/j.jinorgbio.2021.111580	2021	DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.	BCL2
34440193	10.3390/biomedicines9080990	2021	Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer.	BCL2
34445685	10.3390/ijms22168980	2021	A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes.	BCL2
34465079	10.4132/jptm.2021.07.25	2021	Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.	BCL2
34477080		2021	Indurated Plaques on the Legs: Think Lymphoma.	BCL2
34478505	10.1182/bloodadvances.2021005083	2021	Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.	BCL2
34479596	10.1186/s13005-021-00287-x	2021	Influences of cold atmospheric plasma on apoptosis related molecules in osteoblast-like cells in vitro.	BCL2
34488262	10.3760/cma.j.cn121094-20201010-00568	2021	[Changes and significance of autophagy in rat lung injury induced by gas explosion].	BCL2
34489160	10.1016/j.jjcc.2021.08.018	2021	LncRNA MIAT knockdown alleviates oxygen-glucose deprivation‑induced cardiomyocyte injury by regulating JAK2/STAT3 pathway via miR-181a-5p.	BCL2
34490824	10.1177/15347354211035450	2021	Thymoquinone and Costunolide Induce Apoptosis of Both Proliferative and Doxorubicin-Induced-Senescent Colon and Breast Cancer Cells.	BCL2
34497195	10.11406/rinketsu.62.1085	2021	[Molecular pathogenesis and treatment of chronic lymphocytic leukemia].	BCL2
34500469	10.1182/bloodadvances.2021004635	2021	Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma.	BCL2
34520298	10.1177/15330338211041193	2021	miR-342-3p Regulates the Proliferation and Apoptosis of NSCLC Cells by Targeting <i>BCL-2</i>.	BCL2
34528238	10.1111/bjh.17729	2021	Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements.	BCL2
34534532	10.1016/j.ejphar.2021.174505	2021	7-[[(4-methyl-2-pyridinyl)amino](2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth - A question of specificity.	BCL2
34551886	10.1016/j.clml.2021.07.029	2021	A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma.	BCL2
34555842	10.1182/bloodadvances.2020003949	2021	A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.	BCL2
34563576	10.1016/j.ijbiomac.2021.09.095	2021	The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.	BCL2
34568060	10.3389/fonc.2021.729106	2021	Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.	BCL2
34576095	10.3390/ijms22189924	2021	Titanium Dioxide Nanoparticles Exacerbate Allergic Airway Inflammation via TXNIP Upregulation in a Mouse Model of Asthma.	BCL2
34576319	10.3390/ijms221810157	2021	BH3 Mimetics in Hematologic Malignancies.	BCL2
34581757	10.1182/bloodadvances.2021004619	2021	Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma.	BCL2
34610523	10.1016/j.oraloncology.2021.105552	2021	Blastoid variant of mantle cell lymphoma in palatine tonsil.	BCL2
34625994	10.1002/ajh.26367	2021	Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.	BCL2
34633547	10.1007/s00894-021-04924-9	2021	Difference in the binding mechanisms of ABT-263/43b with Bcl-xL/Bcl-2: computational perspective on the accurate binding free energy analysis.	BCL2
34634256	10.1016/S2352-3026(21)00273-8	2021	Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study.	BCL2
34638779	10.3390/ijms221910442	2021	B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.	BCL2
34669537	10.1177/09603271211051597	2021	Vinpocetine attenuates fluoxetine-induced liver damage in rats; Role of Nrf2 and PPAR-γ.	BCL2
34669944	10.1093/mtomcs/mfab058	2021	Maternal selenium deficiency suppresses proliferation, induces autophagy dysfunction and apoptosis in the placenta of mice.	BCL2
34671837	10.1007/s00292-021-01011-x	2021	[Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma].	BCL2
34680290	10.3390/cancers13205141	2021	Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.	BCL2
34685497	10.3390/cells10102517	2021	The Dual Role of Autophagy in Crizotinib-Treated ALK<sup>+</sup> ALCL: From the Lymphoma Cells Drug Resistance to Their Demise.	BCL2
34698437	10.1111/jcmm.16999	2021	Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.	BCL2
34706861	10.1136/bjophthalmol-2021-319580	2021	Prevalence and prognostic value of <i>MYD88</i> and <i>CD79B</i> mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma.	BCL2
34707037	10.3960/jslrt.21025	2021	t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.	BCL2
34708625	10.19852/j.cnki.jtcm.2021.05.003	2021	Mechanism of total glucosides from Chishao (Radix Paeoniae Rubra) on proliferation and apoptosis of hepatocellular carcinoma cells via phosphatase and tensin homolog deleted on chromosome ten / phosphatidylinositol 3-kinase / protein kinase B signaling pathway.	BCL2
34712389	10.1155/2021/9013280	2021	Effect of Maternal Marginal Zinc Deficiency on Development, Redox Status, and Gene Expression Related to Oxidation and Apoptosis in an Avian Embryo Model.	BCL2
34718250	10.1097/WNR.0000000000001739	2021	Neuroprotective effect of paeoniflorin in the mouse model of Parkinson's disease through α-synuclein/protein kinase C δ subtype signaling pathway.	BCL2
34722836	10.1016/j.reth.2021.09.005	2021	Xeno-free workflow exhibits comparable efficiency and quality of keratinocytes isolated from human skin biopsies.	BCL2
34732441	10.21873/anticanres.15384	2021	Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma.	BCL2
34732719	10.1038/s41467-021-26400-x	2021	Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.	BCL2
34733114	10.1155/2021/2255017	2021	Increased Death of Peripheral Blood Mononuclear Cells after TLR4 Inhibition in Sepsis Is Not via TNF/TNF Receptor-Mediated Apoptotic Pathway.	BCL2
34733270	10.3389/fimmu.2021.703256	2021	Cytomegalovirus in Haematological Tumours.	BCL2
34736967	10.1016/j.ejphar.2021.174612	2021	Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells.	BCL2
34758330	10.1016/j.celrep.2021.109979	2021	TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.	BCL2
34782660	10.1038/s41598-021-01693-6	2021	Primary central nervous system lymphomas express immunohistochemical factors of autophagy.	BCL2
34789674	10.1097/APO.0000000000000447	2021	Potential Protective Role of TRPM7 and Involvement of PKC/ERK Pathway in Blue Light-Induced Apoptosis in Retinal Pigment Epithelium Cells in Vitro.	BCL2
34791478	10.1093/rpd/ncab163	2021	EVALUATION OF BCL2 AND ITS REGULATORY MIRS, MIR-15-B AND MIR-16 EXPRESSION CHANGES UNDER THE EXPOSURE OF EXTREMELY LOW-FREQUENCY ELECTROMAGNETIC FIELDS ON HUMAN GASTRIC CANCER CELL LINE.	BCL2
34796352	10.5187/jast.2021.e93	2021	Enhanced supply of methionine regulates protein synthesis in bovine mammary epithelial cells under hyperthermia condition.	BCL2
34799660	10.1038/s41388-021-02117-5	2021	Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.	BCL2
34806851	10.20892/j.issn.2095-3941.2021.0193	2021	Prognostic value of <i>BCL2</i> and <i>TP53</i> genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP.	BCL2
34821362	10.1042/BSR20211885	2021	LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.	BCL2
34829668	10.3390/antiox10111797	2021	Impact of Fennel Essential Oil as an Antibiotic Alternative in Rabbit Diet on Antioxidant Enzymes Levels, Growth Performance, and Meat Quality.	BCL2
34830747	10.3390/cancers13225592	2021	Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era.	BCL2
34831318	10.3390/cells10113095	2021	Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity.	BCL2
34837933	10.31557/APJCP.2021.22.11.3723	2021	Investigation the Cytotoxicity of 5-AZA on Acute Lymphoblastic Leukemia Cell Line In Vitro and Characterization the Underlying Molecular Mechanisms of Cell Death and Motility.	BCL2
34839787	10.1080/21655979.2021.2010315	2021	Hsp22 ameliorates lipopolysaccharide-induced myocardial injury by inhibiting inflammation, oxidative stress, and apoptosis.	BCL2
34859100	10.1155/2021/4579850	2021	A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder.	BCL2
34889402	10.1182/hematology.2021000247	2021	Double-hit lymphoma: optimizing therapy.	BCL2
34889425	10.1182/hematology.2021000312	2021	Does MRD have a role in the management of iNHL?	BCL2
34900354	10.1155/2021/6843103	2021	Rare Presentation of Hypoglycemia in a Patient with Anaplastic Large-Cell Lymphoma.	BCL2
34906296		2021	[Naringin inhibits the proliferation and invasion of Eca109 esophageal cancer cells and promotes its apoptosis by blocking JAK/STAT signal pathway].	BCL2
34907175	10.1038/s41467-021-27197-5	2021	Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.	BCL2
34925435	10.3389/fgene.2021.677650	2021	Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.	BCL2
34938664	10.3389/fonc.2021.789891	2021	Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi.	BCL2
34940336	10.3390/gels7040276	2021	Development, Optimization, and In Vitro Evaluation of Novel Oral Long-Acting Resveratrol Nanocomposite In-Situ Gelling Film in the Treatment of Colorectal Cancer.	BCL2
34945004	10.3390/cancers13246384	2021	Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel.	BCL2
34945817	10.3390/jpm11121345	2021	Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies.	BCL2
34945856	10.3390/jpm11121384	2021	Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma.	BCL2
34956871	10.3389/fonc.2021.746577	2021	Clinical Features and Prognostic Significance of <i>NOTCH1</i> Mutations in Diffuse Large B-Cell Lymphoma.	BCL2
34963222	10.3760/cma.j.cn115330-20210125-00036	2021	[The role of RUNX1 in the apoptosis of epithelial cells in nasal polyps].	BCL2
34970357	10.1155/2021/4933194	2021	MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis.	BCL2
34988210	10.21037/atm-21-5975	2021	Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism.	BCL2
35003920	10.7717/peerj.12571	2021	Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway.	BCL2
35004320	10.3389/fonc.2021.795330	2021	Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With <i>MYC</i> and <i>BCL6</i> Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?	BCL2
35077634		2021	Burkitt Lymphoma With Aberrant Immunophenotype Imposing Diagnostic Challenge.	BCL2
35116484	10.21037/tcr-20-2748	2021	""Double hit"" B-lymphoblastic lymphoma with concurrent <i>IGH</i>/<i>BCL2</i> and 8q24/<i>MYC</i> translocations: a case report.	BCL2
35116524	10.21037/tcr-20-3018	2021	Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway.	BCL2
35124663		2021	An uncommon clinical presentation of primary pancreatic lymphoma: Bleeding. Case report and literature review.	BCL2
35127485	10.3389/fonc.2021.780191	2021	Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis.	BCL2
35155650	10.3389/fvets.2021.817183	2021	The Protective Impact of <i>Salsola imbricata</i> Leaf Extract From Taif Against Acrylamide-Induced Hepatic Inflammation and Oxidative Damage: The Role of Antioxidants, Cytokines, and Apoptosis-Associated Genes.	BCL2
35546979	10.22092/ari.2021.356202.1803	2021	Renoprotective Potential of the Ultra-Pure Lipopolysaccharide from Rhodobacter Sphaeroides on Acutely Injured Kidneys in an Animal Model.	BCL2
31838216	10.1016/j.ijid.2019.12.004	2020	Do genetic polymorphisms of B-cell CLL/lymphoma 2 confer susceptibility to anti-tuberculous therapy-associated drug-induced liver injury?	BCL2
31844144	10.1038/s41375-019-0691-6	2020	Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.	BCL2
31880257	10.2174/1389203721666191227122252	2020	Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients.	BCL2
31889428	10.1002/kjm2.12181	2020	miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.	BCL2
31954371	10.1016/j.redox.2019.101403	2020	Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.	BCL2
32100014	10.1093/jnen/nlaa006	2020	Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations.	BCL2
32101329	10.1002/hon.2727	2020	Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.	BCL2
32334477	10.31557/APJCP.2020.21.4.1103	2020	The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.	BCL2
32364682	10.1111/ijlh.13222	2020	Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.	BCL2
32566654	10.1155/2020/1350820	2020	Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study.	BCL2
32580907	10.1016/j.clbc.2020.05.005	2020	p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.	BCL2
32632899	10.1007/s12253-020-00866-4	2020	A Clinicopathological Approach to Odontogenic Cysts: the Role of Cytokeratin 17 and bcl2 Immunohistochemistry in Identifying Odontogenic Keratocysts.	BCL2
32648768	10.1139/bcb-2019-0336	2020	MiR-448 targets BLC2 and inhibits the growth of pituitary adenoma cells.	BCL2
32680911	10.1136/jclinpath-2020-206725	2020	Incidence of single hit Bcl-2 and Bcl-6 rearrangements in DLBCL: the Irish experience.	BCL2
32722781	10.1182/bloodadvances.2020001551	2020	Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma.	BCL2
32921221	10.1080/10428194.2020.1815017	2020	Clinicopathological and prognostic significance of <i>BCL2</i>, <i>BCL6</i>, <i>MYC</i>, and <i>IRF4</i> copy number gains and translocations in follicular lymphoma: a study by FISH analysis.	BCL2
32991338	10.1097/PAS.0000000000001577	2020	High-grade B-Cell Lymphoma With MYC, BCL2, and/or BCL6 Translocations/Rearrangements: Clinicopathologic Features of 51 Cases in a Single Institution of South China.	BCL2
33031695		2020	A Study Investigating the Role of 2 Candidate SNPs in Bax and Bcl-2 Genes in Alzheimer's Disease.	BCL2
33168821	10.1038/s41408-020-00382-3	2020	Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.	BCL2
33233721	10.3390/ijms21228795	2020	Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma.	BCL2
33280526	10.1177/1533033820980098	2020	microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.	BCL2
34171048	10.47162/RJME.61.4.01	2020	Ovarian ectopic pregnancy: the role of complex morphopathological assay. Review and case presentation.	BCL2
29930300	10.1038/s41375-018-0176-z	2019	The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.	BCL2
30075095	10.1016/j.hemonc.2018.07.005	2019	BCL-2 overexpression overcomes cell of origin stratification in diffuse large B-cell lymphoma.	BCL2
30304559	10.1002/jcb.27655	2019	LINC00152 promotes the proliferation of gastric cancer cells by regulating B-cell lymphoma-2.	BCL2
30306208	10.1007/s00277-018-3498-z	2019	MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.	BCL2
30460680	10.1111/bjh.15653	2019	Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.	BCL2
30535471	10.3892/ijmm.2018.4019	2019	MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.	BCL2
30569090	10.3892/mmr.2018.9738	2019	miR‑15a‑3p affects the proliferation, migration and apoptosis of lens epithelial cells.	BCL2
30575108	10.1002/ajh.25385	2019	IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.	BCL2
30623427	10.1002/jcp.28091	2019	The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML.	BCL2
30681073	10.12659/MSM.912082	2019	Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.	BCL2
30741252	10.12659/MSM.912148	2019	microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.	BCL2
30747219	10.3892/or.2019.6980	2019	Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2.	BCL2
30747227	10.3892/mmr.2019.9883	2019	Long noncoding RNA GAS5 promotes apoptosis in primary nucleus pulposus cells derived from the human intervertebral disc via Bcl‑2 downregulation and caspase‑3 upregulation.	BCL2
30801855	10.1111/odi.13070	2019	Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas.	BCL2
30842155	10.21873/anticanres.13235	2019	Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma.	BCL2
30940629	10.1124/dmd.118.085605	2019	Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy.	BCL2
31036603	10.1042/BSR20182321	2019	miR-1915-3p inhibits Bcl-2 expression in the development of gastric cancer.	BCL2
31103719	10.1016/j.canlet.2019.05.009	2019	A feedforward relationship between active Rac1 and phosphorylated Bcl-2 is critical for sustaining Bcl-2 phosphorylation and promoting cancer progression.	BCL2
31127909	10.31557/APJCP.2019.20.5.1463	2019	C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma	BCL2
31145521	10.1111/cas.14083	2019	Cysteine-rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl-2 pathway.	BCL2
31160589	10.1038/s41467-019-10363-1	2019	Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.	BCL2
31203382	10.1007/s00411-019-00802-4	2019	Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment.	BCL2
31218746	10.1002/jcb.29207	2019	miR-34a-5p was involved in chronic intermittent hypoxia-induced autophagy of human coronary artery endothelial cells via Bcl-2/beclin 1 signal transduction pathway.	BCL2
31234236	10.1111/bjh.16069	2019	Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.	BCL2
31315646	10.1186/s13000-019-0856-7	2019	Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.	BCL2
31337422	10.1186/s13148-019-0706-1	2019	Suv39h1 promotes facet joint chondrocyte proliferation by targeting miR-15a/Bcl2 in idiopathic scoliosis patients.	BCL2
31358732	10.1038/s41419-019-1801-0	2019	Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling.	BCL2
31379128	10.15252/embr.201847026	2019	Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.	BCL2
31397599	10.1139/cjpp-2018-0743	2019	Inhibition of microRNA-34a mediates protection of thymosin beta 4 in endothelial progenitor cells against advanced glycation endproducts by targeting B-cell lymphoma 2.	BCL2
31410188	10.7150/thno.36254	2019	Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy.	BCL2
31417030	10.4103/ijmr.IJMR_1455_17	2019	Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 (<sup>131</sup>I) irradiation.	BCL2
31485613	10.3892/mmr.2019.10610	2019	Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.	BCL2
31644584	10.1371/journal.pone.0224247	2019	Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.	BCL2
31683398	10.3760/cma.j.issn.0253-9624.2019.11.009	2019	[The association of <i>Bcl</i>-2 gene polymorphism with the esophageal cancer and gastric cardia adenocarcinoma in Hebei Province].	BCL2
31702637	10.1097/MD.0000000000017827	2019	Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma.	BCL2
31737898	10.1042/BSR20191773	2019	MicroRNA-15a modulates lens epithelial cells apoptosis and proliferation through targeting B-cell lymphoma-2 and E2F transcription factor 3 in age-related cataracts.	BCL2
31825969	10.1371/journal.pcbi.1007485	2019	Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.	BCL2
28701032	10.4143/crt.2017.134	2018	BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.	BCL2
28718205	10.1002/cyto.b.21541	2018	Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.	BCL2
28777433	10.5301/ijbm.5000291	2018	Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients.	BCL2
28805013	10.1002/mabi.201700196	2018	Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway.	BCL2
28824170	10.1038/leu.2017.270	2018	Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.	BCL2
28875547	10.1111/bjh.14912	2018	Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.	BCL2
28914671	10.1097/PGP.0000000000000442	2018	Endometrial Polyps and Benign Endometrial Hyperplasia Have Increased Prevalence of DNA Fragmentation Factors 40 and 45 (DFF40 and DFF45) Together With the Antiapoptotic B-Cell Lymphoma (Bcl-2) Protein Compared With Normal Human Endometria.	BCL2
29131545	10.1111/febs.14324	2018	A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.	BCL2
29207009	10.3892/ijmm.2017.3260	2018	TAT‑fused IP3R‑derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release.	BCL2
29246583	10.1016/j.bbagen.2017.12.003	2018	DNA structural basis for fragility at peak III of BCL2 major breakpoint region associated with t(14;18) translocation.	BCL2
29328455	10.3892/mmr.2018.8381	2018	Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.	BCL2
29422088	10.1186/s13195-018-0344-4	2018	Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer's disease.	BCL2
29484432	10.3892/ijo.2018.4285	2018	miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.	BCL2
29666157	10.1136/jclinpath-2018-205039	2018	CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.	BCL2
29669301	10.1016/j.biopha.2018.04.002	2018	LIN28B promotes the progression of colon cancer by increasing B-cell lymphoma 2 expression.	BCL2
29680307	10.1016/j.arcmed.2018.04.006	2018	Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.	BCL2
29708579	10.5146/tjpath.2018.01430	2018	Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma.	BCL2
29747654	10.1186/s13045-018-0608-2	2018	BCL-2 as therapeutic target for hematological malignancies.	BCL2
29801406	10.22034/APJCP.2018.19.5.1229	2018	Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience	BCL2
29902576	10.1016/j.humpath.2018.06.006	2018	Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.	BCL2
29983382	10.1016/j.clml.2018.06.010	2018	Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL.	BCL2
30015962	10.3892/or.2018.6581	2018	Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.	BCL2
30043475	10.1002/dc.24038	2018	""Triple hit"" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements.	BCL2
30058688	10.26355/eurrev_201807_15502	2018	Expressions and effects of G250, Bax and Bcl-2 in rats with renal clear cell carcinoma.	BCL2
30152851	10.3892/mmr.2018.9428	2018	Estrogen restricts the apoptosis of endometrial stromal cells by promoting TSLP secretion.	BCL2
30168854	10.1111/aogs.13452	2018	Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.	BCL2
30297390	10.1136/jim-2018-000804	2018	Prostate cancer aggressiveness and age: Impact of p53, BCL-2 and microvessel density.	BCL2
30687320	10.3389/fimmu.2018.03114	2018	Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.	BCL2
27098707	10.1111/bjh.14089	2017	Association of BAX G(-248)A and BCL2 C(-717)A polymorphisms with outcome in diffuse large B-cell lymphoma patients.	BCL2
27696517	10.1002/ajh.24571	2017	CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?	BCL2
27840321	10.1016/j.freeradbiomed.2016.11.010	2017	Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2.	BCL2
28079890	10.1038/cddis.2016.469	2017	Structural insight into an evolutionarily ancient programmed cell death regulator - the crystal structure of marine sponge BHP2 bound to LB-Bak-2.	BCL2
28154089	10.3324/haematol.2016.159087	2017	Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma.	BCL2
28212447	10.1371/journal.pone.0172364	2017	Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.	BCL2
28260044	10.3892/mmr.2017.6233	2017	microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.	BCL2
28280358	10.2147/OTT.S128819	2017	miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.	BCL2
28327893	10.1093/annonc/mdx022	2017	BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.	BCL2
28351336	10.1177/1010428317695965	2017	B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells.	BCL2
28351934	10.1182/blood-2016-11-747022	2017	Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.	BCL2
28379541	10.1093/molehr/gax022	2017	Resistance to apoptosis and autophagy leads to enhanced survival in Sertoli cells.	BCL2
28393810	10.4103/ijdr.IJDR_158_16	2017	Expression of E-cadherin and B-cell lymphoma 2 in oral cancer: A ratio-based planning for targeted therapy.	BCL2
28396899	10.1007/s00066-017-1126-9	2017	BCL2 genotypes and prostate cancer survival.	BCL2
28428442	10.1158/1535-7163.MCT-16-0555	2017	Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.	BCL2
28514780	10.1159/000474926	2017	Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.	BCL2
28522442	10.1182/blood-2016-12-759621	2017	BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.	BCL2
28586007	10.3892/ijo.2017.4028	2017	APG-1252-12A induces mitochondria-dependent apoptosis through inhibiting the antiapoptotic proteins Bcl-2/Bcl-xl in HL-60 cells.	BCL2
28716711	10.1016/j.gene.2017.07.043	2017	Epigenetic silencing of miRNA-143 regulates apoptosis by targeting BCL2 in human intervertebral disc degeneration.	BCL2
28849107	10.3892/mmr.2017.7369	2017	GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2.	BCL2
28862228	10.4103/0973-1482.183197	2017	A study of the distribution of B-cell lymphoma/leukemia-2 in odontogenic cyst and tumors: Histochemical study.	BCL2
28888575	10.1016/j.gene.2017.09.009	2017	Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.	BCL2
28952038	10.1007/s11912-017-0629-y	2017	Double-Hit Large B Cell Lymphoma.	BCL2
28972015	10.1182/blood-2017-06-792150	2017	Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.	BCL2
29020630	10.1016/j.celrep.2017.09.052	2017	Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis.	BCL2
29044419	10.1093/jnen/nlx083	2017	MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.	BCL2
29061914	10.1042/BCJ20170080	2017	Therapeutics targeting Bcl-2 in hematological malignancies.	BCL2
29088292	10.1371/journal.pone.0186983	2017	Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.	BCL2
29198442	10.1016/j.trecan.2017.09.008	2017	Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma.	BCL2
29254309		2017	Association of BCL-2 with oxidative stress and total antioxidant status in pediatric acute lymphoblastic leukemia.	BCL2
25843436	10.3109/15622975.2015.1019360	2016	CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis.	BCL2
26311051	10.1007/s13277-015-3934-9	2016	Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.	BCL2
26350953	10.1177/1535370215600548	2016	Hypoxia promotes apoptosis of neuronal cells through hypoxia-inducible factor-1α-microRNA-204-B-cell lymphoma-2 pathway.	BCL2
26390147	10.3109/10428194.2015.1096352	2016	Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.	BCL2
26421520	10.3109/10428194.2015.1101099	2016	Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma.	BCL2
26448193	10.1097/PAS.0000000000000542	2016	High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.	BCL2
26467384	10.1158/1078-0432.CCR-15-1191	2016	Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.	BCL2
26565895	10.1002/cncr.29781	2016	Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.	BCL2
26621338	10.1038/leu.2015.330	2016	Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.	BCL2
26639348	10.1056/NEJMoa1513257	2016	Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.	BCL2
26658664	10.1097/PAS.0000000000000567	2016	Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.	BCL2
26662799	10.1007/s13277-015-4554-0	2016	Influence of BCL2-938 C&gt;A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.	BCL2
26725534	10.1016/j.prp.2015.12.001	2016	Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.	BCL2
26795455	10.1016/j.bbamcr.2016.01.006	2016	Histone demethylase Jmjd3 regulates osteoblast apoptosis through targeting anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bim.	BCL2
26878773	10.1016/j.freeradbiomed.2016.02.009	2016	Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.	BCL2
26905515	10.1007/s00296-016-3443-1	2016	Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.	BCL2
26919255	10.18632/oncotarget.7687	2016	Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.	BCL2
27008505	10.1371/journal.pone.0152142	2016	RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2.	BCL2
27016043	10.1002/bip.22839	2016	Exploring the conformational and binding properties of unphosphorylated/phosphorylated monomeric and trimeric Bcl-2 through docking and molecular dynamics simulations.	BCL2
27071312	10.3109/10428194.2016.1167205	2016	Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.	BCL2
27129202	10.1074/jbc.M116.715235	2016	Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins.	BCL2
27134111	10.1016/j.humpath.2016.04.004	2016	Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.	BCL2
27157620	10.1038/onc.2016.155	2016	FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.	BCL2
27159593	10.1002/art.39744	2016	Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.	BCL2
27176117	10.3892/mmr.2016.5255	2016	MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2.	BCL2
27286976	10.1186/s12885-016-2397-8	2016	MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.	BCL2
27391453	10.1097/DAD.0000000000000607	2016	Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.	BCL2
27509922	10.3892/mmr.2016.5608	2016	Investigation of the association between miR‑181b, Bcl‑2 and LRIG1 in oral verrucous carcinoma.	BCL2
27524613	10.1016/j.celrep.2016.07.053	2016	Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.	BCL2
27543313	10.1016/j.mrrev.2016.06.001	2016	Functional Implications of the spectrum of BCL2 mutations in Lymphoma.	BCL2
27544800	10.1016/j.humpath.2016.07.025	2016	Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.	BCL2
27578251	10.1038/srep32189	2016	The long noncoding RNA ASNR regulates degradation of Bcl-2 mRNA through its interaction with AUF1.	BCL2
27633052	10.3892/mmr.2016.5733	2016	Upregulation of DAPK contributes to homocysteine-induced endothelial apoptosis via the modulation of Bcl2/Bax and activation of caspase 3.	BCL2
27748813	10.3892/mmr.2016.5808	2016	Protocadherin γ A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth.	BCL2
27773559	10.1016/j.jfma.2016.09.006	2016	Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan.	BCL2
23925400	10.1177/1076029613498816	2015	VEGFR-1, Bcl-2, and HO-1 Ratios in Pregnant Women With Hypertension.	BCL2
24496723	10.1002/hon.2132	2015	BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.	BCL2
24679006	10.3109/10428194.2014.907896	2015	TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.	BCL2
25103070	10.1038/modpathol.2014.95	2015	B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas.	BCL2
25257838	10.1007/s12094-014-1226-2	2015	CC genotype of anti-apoptotic gene BCL-2 (-938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer.	BCL2
25284491	10.3109/10428194.2014.970550	2015	Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.	BCL2
25284608	10.1111/bjh.13149	2015	Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways.	BCL2
25311206	10.1007/s12035-014-8908-1	2015	Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease.	BCL2
25336632	10.1182/blood-2014-05-576470	2015	Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.	BCL2
25342468	10.1038/cdd.2014.176	2015	Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.	BCL2
25381338	10.1158/1078-0432.CCR-14-1913	2015	Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.	BCL2
25384499	10.3892/or.2014.3595	2015	Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.	BCL2
25388617	10.1007/s00109-014-1221-7	2015	BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.	BCL2
25449296	10.1007/s12013-014-0139-6	2015	LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.	BCL2
25452615	10.1182/blood-2014-04-571786	2015	BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.	BCL2
25484022	10.3892/or.2014.3655	2015	Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation.	BCL2
25549806	10.3109/10428194.2014.999324	2015	Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood.	BCL2
25563670	10.1016/j.psychres.2014.12.020	2015	Bcl-2 associated with severity of manic symptoms in bipolar patients in a manic phase.	BCL2
25604244	10.1179/1973947814Y.0000000234	2015	TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2.	BCL2
25631043	10.1074/jbc.M114.627679	2015	The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.	BCL2
25648135	10.1007/s10549-015-3288-4	2015	Bcl2 and Ki67 refine prognostication in luminal breast cancers.	BCL2
25682076	10.1007/s10549-015-3305-7	2015	Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.	BCL2
25687653	10.1038/leu.2015.43	2015	Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.	BCL2
25715028	10.1080/15548627.2015.1017191	2015	BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.	BCL2
25738398	10.3892/mmr.2015.3385	2015	B-cell lymphoma 2 and β-catenin expression in colorectal cancer and their prognostic role following surgery.	BCL2
25741152	10.3748/wjg.v21.i8.2433	2015	Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.	BCL2
25748272	10.1016/j.tem.2015.02.004	2015	Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins.	BCL2
25815462	10.3892/mmr.2015.3534	2015	Apoptosis of HL-60 human leukemia cells induced by Asiatic acid through modulation of B-cell lymphoma 2 family proteins and the mitogen-activated protein kinase signaling pathway.	BCL2
25828389	10.1097/PAS.0000000000000433	2015	MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.	BCL2
25828391	10.1097/PAS.0000000000000434	2015	Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.	BCL2
25854572		2015	[Expressions and significance of NDRG2 and Bcl-2 in human gastric cancer tissues].	BCL2
25862909		2015	miR-7 expression in serous ovarian carcinomas.	BCL2
25867342	10.4238/2015.March.20.6	2015	Effect of TIEG1 on apoptosis and expression of Bcl-2/Bax and Pten in leukemic cell lines.	BCL2
25882699	10.1038/leu.2015.99	2015	Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.	BCL2
25957473	10.1016/j.bbrc.2015.04.131	2015	Regulation of the ryanodine receptor by anti-apoptotic Bcl-2 is independent of its BH3-domain-binding properties.	BCL2
25957891	10.1007/s13277-015-3457-4	2015	Influence of BCL2-938C&gt;A and BAX-248G&gt;A promoter polymorphisms in the development of AML: case-control study from South India.	BCL2
25975837	10.3324/haematol.2014.118828	2015	ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.	BCL2
25982455	10.1007/s00432-015-1982-6	2015	Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.	BCL2
25984893	10.1080/15548627.2015.1034402	2015	The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.	BCL2
26009182	10.1042/BST20140298	2015	Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation.	BCL2
26035796	10.3892/or.2015.4011	2015	Hypoxia-induced apoptosis is blocked by adrenomedullin via upregulation of Bcl-2 in human osteosarcoma cells.	BCL2
26081683	10.3892/mmr.2015.3939	2015	Quantitative analysis of the mRNA expression levels of BCL2 and BAX genes in human osteoarthritis and normal articular cartilage: An investigation into their differential expression.	BCL2
26091803	10.1186/s12885-015-1485-5	2015	Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells.	BCL2
26110568	10.18632/oncotarget.4230	2015	Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.	BCL2
26132559	10.1038/srep11833	2015	Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma.	BCL2
26158410	10.18632/oncotarget.4073	2015	MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma.	BCL2
26172269	10.1371/journal.pone.0132926	2015	BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?	BCL2
26214636		2015	BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.	BCL2
26239087	10.1182/blood-2015-03-630012	2015	Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.	BCL2
26431330	10.18632/oncotarget.5901	2015	Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.	BCL2
26458963	10.3892/mmr.2015.4363	2015	Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells.	BCL2
26475474	10.1186/s12885-015-1778-8	2015	P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma.	BCL2
26482649	10.1186/s13000-015-0427-5	2015	Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas?	BCL2
26515759	10.1186/s13045-015-0218-1	2015	Establishment and characterization of a novel MYC/BCL2 ""double-hit"" diffuse large B cell lymphoma cell line, RC.	BCL2
26546525		2015	Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.	BCL2
26558423	10.3109/08880018.2015.1087611	2015	De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.	BCL2
26634708	10.1007/s11864-015-0374-0	2015	Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.	BCL2
26638586		2015	The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).	BCL2
26717387	10.1097/MD.0000000000002388	2015	Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study.	BCL2
26782527	10.4238/2015.December.28.26	2015	Effect of transvaginal ultrasound on human chorionic villus cell apoptosis during pregnancy.	BCL2
26823859		2015	B-cell lymphoma 2 rs17757541 C&gt;G polymorphism was associated with an increased risk of coronary artery disease in a Chinese population.	BCL2
23975374	10.1007/s13277-013-1115-2	2014	MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.	BCL2
24024471	10.3109/10428194.2013.842992	2014	Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.	BCL2
24028527	10.1080/07391102.2013.833858	2014	A study of the structural properties and thermal stability of human Bcl-2 by molecular dynamics simulations.	BCL2
24038028	10.3324/haematol.2013.085340	2014	Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia.	BCL2
24118498	10.1111/ejh.12212	2014	MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations.	BCL2
24190693	10.1007/s00404-013-3060-0	2014	Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors.	BCL2
24232982	10.1007/s10120-013-0313-3	2014	Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.	BCL2
24280866	10.1038/leu.2013.361	2014	Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.	BCL2
24287948	10.1007/s13277-013-1299-5	2014	Association of BCL2-938C&gt;A genetic polymorphism with glioma risk in Chinese Han population.	BCL2
24321200	10.1016/j.jad.2013.11.010	2014	Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.	BCL2
24338002	10.1007/s10555-013-9450-8	2014	Why anti-Bcl-2 clinical trials fail: a solution.	BCL2
24387269	10.1186/1471-2490-14-2	2014	Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma.	BCL2
24397922	10.1016/j.mce.2013.10.024	2014	Up-regulation of Bcl-2 during adipogenesis mediates apoptosis resistance in human adipocytes.	BCL2
24496564	10.1007/s12032-014-0872-0	2014	Phase II study of low-dose fixed-rate infusion of gemcitabine combined with cisplatin and dexamethasone in resistant non-Hodgkin lymphoma and correlation with Bcl-2 and MDR expression.	BCL2
24503222	10.1016/j.tibs.2013.12.006	2014	Many players in BCL-2 family affairs.	BCL2
24621205	10.3109/00365513.2014.891257	2014	Association of BH3 interacting domain death agonist (BID) gene polymorphisms with proteinuria of immunoglobulin A nephropathy.	BCL2
24626299	10.1371/journal.pone.0091782	2014	BEX1 promotes imatinib-induced apoptosis by binding to and antagonizing BCL-2.	BCL2
24762814	10.1242/jcs.150011	2014	Bcl-2 binds to and inhibits ryanodine receptors.	BCL2
24768714	10.1016/j.bbamcr.2014.04.017	2014	A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.	BCL2
24786774	10.1182/blood-2014-03-560284	2014	Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.	BCL2
25016705	10.7754/clin.lab.2013.130517	2014	Bcl-2/IgH expression of diffuse large B-cell lymphoma cells in minimal bone marrow infiltration.	BCL2
25031780		2014	miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.	BCL2
25066397	10.1016/S1995-7645(14)60077-8	2014	Expression heterogeneity research of ITGB3 and BCL-2 in lung adenocarcinoma tissue and adenocarcinoma cell line.	BCL2
25086254	10.1016/j.bbagen.2014.07.014	2014	A newly identified G-quadruplex as a potential target regulating Bcl-2 expression.	BCL2
25090026	10.1371/journal.pone.0104068	2014	MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.	BCL2
25177684	10.1155/2014/234370	2014	Bcl-2 family proteins are involved in the signal crosstalk between endoplasmic reticulum stress and mitochondrial dysfunction in tumor chemotherapy resistance.	BCL2
25179840	10.1007/s13277-014-2534-4	2014	Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy.	BCL2
25279986	10.1016/j.ajhg.2014.09.004	2014	Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.	BCL2
25301704	10.1182/blood-2014-05-574566	2014	ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.	BCL2
25362242	10.18632/oncotarget.2605	2014	Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2.	BCL2
25384217	10.1172/JCI72415	2014	Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.	BCL2
25430556	10.1038/srep07241	2014	Role of Bcl-2 -938 C&gt;A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.	BCL2
22484426	10.1038/onc.2012.117	2013	Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies.	BCL2
22929980	10.3324/haematol.2012.066209	2013	Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.	BCL2
22933114	10.2337/db11-1464	2013	Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells.	BCL2
23072837	10.1038/npp.2012.203	2013	Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.	BCL2
23076250	10.3892/mmr.2012.1131	2013	Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme.	BCL2
23126236	10.1111/jop.12020	2013	Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.	BCL2
23135964	10.1002/alr.21107	2013	Upregulation of Bcl-2 in nasal polyps from patients with cystic fibrosis.	BCL2
23263985	10.1128/MCB.01436-12	2013	Both CpG methylation and activation-induced deaminase are required for the fragility of the human bcl-2 major breakpoint region: implications for the timing of the breaks in the t(14;18) translocation.	BCL2
23335369	10.1182/blood-2012-06-435842	2013	MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.	BCL2
23359021	10.4238/2013.January.16.6	2013	Assessment of BCL2/J(H) translocation in healthy individuals exposed to low-level radiation of 137CsCl in Goiânia, Goiás, Brazil.	BCL2
23363601	10.1091/mbc.E12-10-0747	2013	Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells.	BCL2
23403511	10.1093/abbs/gmt002	2013	Rapamycin increases pCREB, Bcl-2, and VEGF-A through ERK under normoxia.	BCL2
23422486		2013	No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotides.	BCL2
23431138	10.1073/pnas.1217271110	2013	Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.	BCL2
23437205	10.1371/journal.pone.0056663	2013	Effect of Bcl-2 rs956572 polymorphism on age-related gray matter volume changes.	BCL2
23449635	10.1182/blood-2012-10-460063	2013	MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.	BCL2
23471820	10.1158/2159-8290.CD-12-0504	2013	TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.	BCL2
23479509	10.1593/neo.121392	2013	Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.	BCL2
23494176	10.1007/s13277-013-0647-9	2013	High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma.	BCL2
23509938	10.1111/his.12076	2013	Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.	BCL2
23511489	10.1097/MPH.0b013e318286d29b	2013	The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.	BCL2
23613627	10.3748/wjg.v19.i15.2340	2013	Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.	BCL2
23770605	10.1038/ng.2652	2013	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	BCL2
23784204	10.3892/or.2013.2539	2013	Bcl-2 gene silencing by RNA interference inhibits the growth of the human gallbladder carcinoma cell line GBC-SD in vitro and in vivo.	BCL2
23851330	10.1097/PAS.0b013e31828b6ad3	2013	Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma.	BCL2
23939148	10.1097/PAP.0b013e3182a289f2	2013	MYC/BCL2 double-hit high-grade B-cell lymphoma.	BCL2
23953419	10.1016/j.oooo.2013.06.014	2013	Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization.	BCL2
23991993	10.7314/apjcp.2013.14.7.4301	2013	B-cell Lymphoma 2 rs17757541 C&gt;G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population.	BCL2
23998360	10.1016/j.psychres.2013.08.032	2013	Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase.	BCL2
24088574	10.1186/1471-2407-13-452	2013	The BCL2-938 C &gt; A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.	BCL2
20981461	10.1007/s10006-010-0254-5	2012	Diffuse swelling of the buccal mucosa and palate as first and only manifestation of an extranodal non-Hodgkin 'double-hit' lymphoma: report of a case.	BCL2
21618512	10.1002/ijc.26183	2012	Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.	BCL2
21793937	10.1111/j.1600-0714.2011.01066.x	2012	The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.	BCL2
21855110	10.1016/j.humpath.2011.05.018	2012	Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.	BCL2
21988644	10.3109/10428194.2011.631158	2012	The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells.	BCL2
22002575	10.1038/modpathol.2011.147	2012	B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.	BCL2
22037714	10.1016/j.yexmp.2011.09.004	2012	Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.	BCL2
22054286	10.3109/10428194.2011.637212	2012	Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma.	BCL2
22081075	10.1038/onc.2011.508	2012	Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression.	BCL2
22138435	10.1016/j.canlet.2011.11.030	2012	Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.	BCL2
22187149	10.1007/s12032-011-0135-2	2012	The -938A/A genotype of BCL2 gene is associated with esophageal cancer.	BCL2
22189900	10.1038/leu.2011.378	2012	BCL2 mutations in diffuse large B-cell lymphoma.	BCL2
22262057	10.1002/jcp.24057	2012	Inactivation of Bcl-2 through IκB kinase (IKK)-dependent phosphorylation mediates apoptosis upon exposure to 4-hydroxynonenal (HNE).	BCL2
22275374	10.1074/jbc.M111.307363	2012	Mechanism of fragility at BCL2 gene minor breakpoint cluster region during t(14;18) chromosomal translocation.	BCL2
22322190	10.1038/modpathol.2012.1	2012	BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.	BCL2
22393362	10.1371/journal.pone.0031366	2012	Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.	BCL2
22395507		2012	Immunologic and cytogenetic markers expressed in non-Hodgkin lymphoma of head and neck.	BCL2
22406486	10.1097/PAT.0b013e3283513fb2	2012	Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.	BCL2
22517702		2012	The predictive role of Bcl-2 expression in operable locally advanced or metastatic gastric carcinoma.	BCL2
22562364	10.3892/or.2012.1800	2012	Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells.	BCL2
22591684	10.1016/j.leukres.2012.03.020	2012	Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.	BCL2
22666341	10.1371/journal.pone.0037045	2012	Multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of Cr(VI)-transformed lung cells.	BCL2
22732796		2012	Study of molecular prognostic factors Bcl-2 and EGFR in rectal mucinous carcinomas.	BCL2
22804688	10.1111/j.1365-2559.2012.04301.x	2012	High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.	BCL2
22851565	10.1200/JCO.2011.41.0985	2012	Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.	BCL2
22855608	10.1182/blood-2012-05-429514	2012	Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.	BCL2
22949148	10.1200/JCO.2012.44.4729	2012	Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas.	BCL2
22951829	10.1128/JVI.01136-12	2012	Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.	BCL2
22953646		2012	Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.	BCL2
22968395	10.1097/PDM.0b013e3182585c3c	2012	Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.	BCL2
23018213	10.1097/PGP.0b013e31824df26b	2012	ATF5 is overexpressed in epithelial ovarian carcinomas and interference with its function increases apoptosis through the downregulation of Bcl-2 in SKOV-3 cells.	BCL2
23207618	10.1159/000343664	2012	Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin's lymphoma.	BCL2
23324193		2012	[Expression and significance of bcl-2, bax and ER in foci of adenomyosis].	BCL2
20836993	10.1016/j.bcp.2010.09.002	2011	Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxib-induced apoptosis.	BCL2
20952062	10.1016/j.leukres.2010.09.011	2011	Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.	BCL2
21167476	10.1016/j.biopsych.2010.10.019	2011	The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.	BCL2
21233846	10.1038/cdd.2010.175	2011	Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.	BCL2
21320251	10.1111/j.1399-5618.2011.00897.x	2011	Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder.	BCL2
21412927	10.1002/gcc.20863	2011	A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1.	BCL2
21442307	10.1007/s10495-011-0593-1	2011	Nonlinear regulation of commitment to apoptosis by simultaneous inhibition of Bcl-2 and XIAP in leukemia and lymphoma cells.	BCL2
21444675	10.1158/0008-5472.CAN-10-3119	2011	Bcl-2 inhibits nuclear homologous recombination by localizing BRCA1 to the endomembranes.	BCL2
21454712	10.1074/jbc.M110.189092	2011	Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells.	BCL2
21457555	10.1186/1471-2350-12-48	2011	BCL-2 (-938C &gt; A) polymorphism is associated with breast cancer susceptibility.	BCL2
21474673	10.1182/blood-2010-08-301283	2011	The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity.	BCL2
21508398		2011	Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation.	BCL2
21518495		2011	[Expression and significance of B cell-activating factor of TNF family (BAFF) and B cell lymphoma/leukemia-2 (BCL-2) in multiple myeloma].	BCL2
21560251	10.1002/cncy.20156	2011	Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).	BCL2
21560252	10.1002/cncy.20160	2011	Cytopathology of ""double-hit"" non-Hodgkin lymphoma.	BCL2
21622563	10.1074/jbc.M110.212944	2011	Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).	BCL2
21628855	10.3960/jslrt.51.7	2011	BCL2 and MYC dual-hit lymphoma/leukemia.	BCL2
21640157	10.1016/j.exphem.2011.05.002	2011	Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.	BCL2
21640710	10.1016/j.bbrc.2011.05.118	2011	MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression.	BCL2
21658611	10.1016/j.beha.2011.02.003	2011	Pathology, pathogenesis and molecular genetics of follicular NHL.	BCL2
21680733	10.1074/jbc.M111.235689	2011	Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.	BCL2
21738398		2011	Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.	BCL2
21914345		2011	[Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].	BCL2
21933893	10.1158/1078-0432.CCR-11-0267	2011	BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.	BCL2
21940310	10.5754/hge10765	2011	Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro.	BCL2
22022968	10.1134/S0006297911080104	2011	Mitogen-activated protein kinases mediate the production of B-cell lymphoma 2 protein by Mycobacterium tuberculosis in monocytes.	BCL2
22194861	10.1371/journal.pone.0028585	2011	EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas.	BCL2
24048795	10.1002/cncr.25811	2011	Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.	BCL2
19925052	10.3109/10428190903370338	2010	Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.	BCL2
19968497	10.3109/07357900903095714	2010	Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C&gt;T, BCL2-938C&gt;A, MCL1-386C&gt;G) in extrahepatic cholangiocarcinoma.	BCL2
20001236	10.3109/10428190903350421	2010	Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.	BCL2
20045442	10.1016/j.exphem.2009.12.005	2010	Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.	BCL2
20087644	10.1007/s10552-010-9504-y	2010	Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.	BCL2
20118770	10.1097/PAS.0b013e3181cd3aeb	2010	B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.	BCL2
20181625		2010	Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.	BCL2
20350212	10.3109/00313021003631296	2010	Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.	BCL2
20352431	10.1007/s00277-010-0945-x	2010	Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.	BCL2
20368567	10.1200/JCO.2009.25.0852	2010	BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.	BCL2
20415745	10.1111/j.1600-0781.2010.00496.x	2010	Bcl-2 expression in mycosis fungoides before and after PUVA therapy.	BCL2
20459572	10.1111/j.1365-2559.2010.03524.x	2010	The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.	BCL2
20564216	10.1002/jcb.22635	2010	Poly (ADP-ribose) polymerase-1 binds to BCL2 major breakpoint region and regulates BCL2 expression.	BCL2
20723300		2010	[Effect of bortezomib on lymphoma cell line CA46 and its relative mechanisms].	BCL2
20855536	10.1158/1055-9965.EPI-10-0581	2010	Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.	BCL2
20951945	10.1016/j.ccr.2010.09.009	2010	T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.	BCL2
21131755	10.4103/0019-509X.73576	2010	Detection of B cell lymphoma 2, tumor protein 53, and FAS gene transcripts in blood cells of patients with breast cancer.	BCL2
18929412	10.1016/j.leukres.2008.09.007	2009	High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.	BCL2
19141121	10.1111/j.1600-0609.2009.01222.x	2009	Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.	BCL2
19152170	10.1080/10428190802626616	2009	Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP.	BCL2
19196738	10.1093/annonc/mdn763	2009	The regulatory BCL2 promoter polymorphism (-938C&gt;A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.	BCL2
19276283	10.1158/1078-0432.CCR-08-1588	2009	Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.	BCL2
19336552	10.1158/1055-9965.EPI-08-1037	2009	Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.	BCL2
19417623	10.1097/PAI.0b013e3181a20307	2009	FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients.	BCL2
19448593	10.1038/modpathol.2009.73	2009	Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.	BCL2
19452318	10.1080/10428190902803677	2009	Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.	BCL2
19460716		2009	[Expressions of proliferating cell nuclear antigen, Bcl-2, and Bax in lymphocytes of patients with oral lichen planus].	BCL2
19520857	10.1074/jbc.M109.023721	2009	B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity.	BCL2
19535347	10.3324/haematol.2008.005355	2009	Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.	BCL2
19537891		2009	Frequency of bcl-2 gene rearrangement in B-cell Non-Hodgkin's lymphoma.	BCL2
19549844	10.1073/pnas.0903854106	2009	BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.	BCL2
19550126		2009	Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.	BCL2
19557638	10.1080/10428190902943069	2009	Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737.	BCL2
19573080	10.1111/j.1365-2141.2009.07790.x	2009	Common genetic variants in candidate genes and risk of familial lymphoid malignancies.	BCL2
19597184	10.1182/blood-2009-03-212191	2009	Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.	BCL2
19656156	10.1111/j.1349-7006.2009.01268.x	2009	Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.	BCL2
19717648	10.1182/blood-2009-01-201111	2009	C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.	BCL2
19725224	10.3727/096504009789735413	2009	Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.	BCL2
19773279	10.1136/oem.2008.044024	2009	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	BCL2
19783718	10.1136/jcp.2009.066597	2009	BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.	BCL2
19883311	10.3109/10428190903207530	2009	BCL2-938C&gt;A polymorphism and disease progression in chronic lymphocytic leukemia.	BCL2
19996270	10.1158/1535-7163.MCT-09-0408	2009	Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.	BCL2
20032416		2009	BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.	BCL2
20034411		2009	Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency.	BCL2
20160358	10.4103/0973-1482.59901	2009	Characterization of genetic lesions in apoptosis-regulating and proliferation control genes in diffuse large B-cell non-Hodgkin's lymphoma.	BCL2
17893875	10.1002/ijc.23071	2008	Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.	BCL2
18046449	10.1038/sj.leu.2405039	2008	The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia.	BCL2
18203018	10.1080/10428190701742472	2008	Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features.	BCL2
18367485	10.3324/haematol.12057	2008	Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.	BCL2
18375822	10.1158/1535-7163.MCT-07-0302	2008	Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.	BCL2
18426731	10.1309/CMPGPYTMFRM6RVQR	2008	Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.	BCL2
18474261	10.1016/j.niox.2008.04.019	2008	Role of S-nitrosylation in apoptosis resistance and carcinogenesis.	BCL2
18493992	10.1002/pbc.21619	2008	Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.	BCL2
18508827	10.1183/09031936.00064508	2008	Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis.	BCL2
18538438	10.1016/j.jhep.2008.03.031	2008	Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas.	BCL2
18622426	10.1038/onc.2008.214	2008	A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.	BCL2
18633450	10.2119/2008.00061.McCarthy	2008	Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).	BCL2
18636124	10.1371/journal.pone.0002816	2008	Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.	BCL2
18695675	10.1038/onc.2008.286	2008	Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.	BCL2
18752503	10.1111/j.1365-2559.2008.03076.x	2008	MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.	BCL2
18758641		2008	Bcl-2 expression in Hodgkin's lymphoma progression.	BCL2
18806751		2008	Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.	BCL2
18940474	10.1016/j.cancergencyto.2008.06.007	2008	BCL2 and BCL3 are recurrent translocation partners of the IGH locus.	BCL2
18957415	10.1074/jbc.M800951200	2008	PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.	BCL2
16949642	10.1016/j.humpath.2006.06.017	2007	Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas.	BCL2
17200714	10.1172/JCI28281	2007	Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.	BCL2
17290286	10.1038/sj.cdd.4402091	2007	Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts.	BCL2
17363905	10.1038/sj.emboj.7601622	2007	Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.	BCL2
17434928	10.1093/carcin/bgm093	2007	Bcl-2 over-expression promotes genomic instability by inhibiting apoptosis of cells exposed to hydrogen peroxide.	BCL2
17473827	10.1038/sj.bjc.6603762	2007	Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma.	BCL2
17652637	10.2353/jmoldx.2007.070038	2007	''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.	BCL2
17692808	10.1016/j.ccr.2007.07.001	2007	BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.	BCL2
17693666	10.1093/carcin/bgm172	2007	Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.	BCL2
17852408	10.1080/08977190701345515	2007	Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas.	BCL2
17875758	10.1158/1078-0432.CCR-07-0283	2007	ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.	BCL2
18055344	10.1532/IJH97.A20709	2007	High frequency of BCL2 translocation in Thai patients with follicular lymphomas.	BCL2
18073527	10.4161/cc.6.24.5023	2007	Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2.	BCL2
16186795	10.1038/sj.onc.1209127	2006	Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.	BCL2
16690525	10.1080/10428190500361128	2006	Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma.	BCL2
16777355	10.1016/j.gene.2006.05.002	2006	The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function.	BCL2
16799010	10.1167/iovs.05-1312	2006	Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.	BCL2
16840204	10.1080/10428190500404498	2006	Preferential survival of acute lymphoblastic leukemia cells at 33 degrees C is associated with up-regulation of bcl-2.	BCL2
17074584	10.1016/j.cancergencyto.2006.05.016	2006	Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas.	BCL2
17097560	10.1016/j.ccr.2006.10.006	2006	Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.	BCL2
15367432	10.1182/blood-2004-07-2548	2005	Immunogenicity of Bcl-2 in patients with cancer.	BCL2
15657349		2005	Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.	BCL2
15716988	10.1038/sj.leu.2403661	2005	Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.	BCL2
15720419	10.1111/j.1365-2559.2005.02099.x	2005	CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.	BCL2
16166262	10.1073/pnas.0506654102	2005	miR-15 and miR-16 induce apoptosis by targeting BCL2.	BCL2
16194898	10.1080/10428190500125648	2005	Translocation of BCL2 and BCL6 to the same immunoglobulin heavy chain locus in a case of follicular lymphoma.	BCL2
16215945		2005	[BCL-2/IgH translocation in peripheral blood cells of healthy Chinese individuals of Han nationality located in Zhejiang area].	BCL2
14724650	10.1038/sj.leu.2403231	2004	Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.	BCL2
14737118	10.1038/sj.onc.1207141	2004	Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.	BCL2
14764541	10.1182/blood-2003-04-1011	2004	Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells.	BCL2
15061204	10.1080/1042819031000147009	2004	Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: results from a population-based non-Hodgkin's lymphoma registry.	BCL2
15196944	10.1016/j.febslet.2004.05.020	2004	Overexpression of GD3 synthase induces apoptosis of vascular endothelial ECV304 cells through downregulation of Bcl-2.	BCL2
15203866	10.1080/1024533042000205496	2004	Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.	BCL2
15561778		2004	Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.	BCL2
12477721	10.1074/jbc.M210202200	2003	Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras.	BCL2
12749011	10.1002/ajh.10333	2003	Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.	BCL2
12835724	10.1038/sj.leu.2402982	2003	NF- kappa B2/p100 induces Bcl-2 expression.	BCL2
12879322	10.1007/s00240-003-0324-3	2003	The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium.	BCL2
12960134		2003	Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.	BCL2
12970736	10.1038/sj.onc.1206639	2003	Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.	BCL2
14689061		2003	Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.	BCL2
11877266	10.1182/blood.v99.6.1959	2002	Clinicopathologic analysis of follicular lymphoma occurring in children.	BCL2
11908736	10.1080/10428190210195	2002	Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21.	BCL2
11999565	10.1080/1042819029000611610	2002	Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.	BCL2
12032828	10.1038/sj.onc.1205483	2002	NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.	BCL2
12036852	10.1182/blood.v99.12.4265	2002	Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation.	BCL2
12036886	10.1182/blood.v99.12.4540	2002	Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.	BCL2
12036888	10.1182/blood.v99.12.4554	2002	Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.	BCL2
12217802		2002	Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.	BCL2
12481899	10.1080/1042819021000015961	2002	Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent manner.	BCL2
12533044	10.1080/1042819021000033024	2002	Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines.	BCL2
12613529	10.1080/1042819021000040107	2002	Absence of somatic hypermutation in the open reading frame of the bcl-2 gene participating in the t(14;18) chromosomal translocation in follicular lymphoma.	BCL2
11325850		2001	Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.	BCL2
11368354	10.1038/sj.leu.2402090	2001	Phosphorylation of Bcl2 and regulation of apoptosis.	BCL2
11804283	10.1023/a:1012946812930	2001	Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.	BCL2
11855781	10.1163/15685590152763737	2001	Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.	BCL2
11877091		2001	[Clinical study of P-gp, and bcl-2 protein expression in non-Hodgkin's lymphomas patients].	BCL2
11949843		2001	Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.	BCL2
9645350	10.1002/(sici)1097-0215(19980619)79:3&lt;273::aid-ijc11&gt;3.0.co;2-9	1998	Mutational analysis of Bax and Bcl-2 in childhood acute lymphoblastic leukaemia.	BCL2
9031086	10.3109/10428199609054864	1996	The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression.	BCL2
7772249	10.1089/dna.1994.13.679	1994	Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein.	BCL2
8022822	10.1073/pnas.91.14.6569	1994	Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes.	BCL2
8090743	10.1073/pnas.91.19.8910	1994	BCL2 translocation frequency rises with age in humans.	BCL2
8183370	10.1038/369321a0	1994	BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.	BCL2
8402648		1993	Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.	BCL2
1286168		1992	The bcl-2 oncogene and apoptosis.	BCL2
1339299		1992	Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.	BCL2
1373874		1992	Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture.	BCL2
1453000	10.1177/40.12.1453000	1992	Ultrastructural localization of bcl-2 protein.	BCL2
1508712	10.1093/nar/20.16.4187	1992	Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo.	BCL2
2250705	10.1038/348334a0	1990	Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.	BCL2
2834197	10.1002/j.1460-2075.1988.tb02791.x	1988	Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.	BCL2
3285301		1988	Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.	BCL2
3523487	10.1073/pnas.83.14.5214	1986	Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.	BCL2
3924412	10.1016/s0092-8674(85)80070-2	1985	Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.	BCL2
